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Abstract
Leukocyte telomere length (TL) shortens with age and is associated with age-related
pathologies. However, inherited and acquired variation in telomere length in individuals
complicates clinical interpretations of TL as a biomarker of aging and age-related
pathologies. Therefore, it is critical to identify a post-mitotic tissue as a surrogate marker of
TL at birth. In my thesis project, I used quantitative PCR to trace TL dynamics of a variety of
tissue types of inbred mice during 1st year of life. I found that TL of smooth muscle of aortic
media did not shorten with age and represents birth TL. Notably, birth TL effectively offset
genetic variation of TL in a genetically diverse mouse population. In addition, I further
revealed that impaired collagen turnover in mice, which leads to premature aging symptoms,
accelerates TL shortening. In summary, I identified that aortic media provides a powerful
internal reference for birth TL with potentials to improve the accuracy of evaluating telomere
shortening in individuals.

Keywords
Telomere length dynamics, T/S ratio, birth telomere length, genetic variation, inbred mice,
Diversity Outbred mice, aortic media.
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Chapter 1 - Introduction
1.1

General introduction

The idea of modifying the course of aging and age-related diseases is a concept that
humans naturally desire to explore with great potential for clinical application. Telomeres
represent a potentially modifiable biomarker of aging that has been linked to age-related
diseases (Oeseburg et al., 2010). Tremendous research efforts, with over 13000 hits on
PubMed, growing continuously each day, are made to uncover the link between
telomeres with aging and various age-related diseases. Telomeres protect chromosomes,
but undergo attrition as DNA replicates or is insulted by environmental stresses
(Oeseburg et al., 2010). In particular, shortening of telomere length (TL) in leukocytes is
a well-established event in human aging (Aviv, 2012). However, an etiological link
between telomeres and aging is yet to be fully elucidated. Understanding the dynamics
of telomeres with normal aging in model organisms (e.g. mice) can help to uncover the
role telomeres play at the organismal level with age.

1.2

Telomere structure

Telomeres are DNA-protein complexes containing repetitive units of DNA that reside at
the end of each chromosome arm in eukaryotes (Figure 1.1) (Oeseburg et al., 2010). The
DNA sequence of telomeres is highly conserved among vertebrates and consists of
several kilobases of TTAGGG repeats (Meyne et al., 1989), ending in a 100-200 bp 3’
overhang (Makarov et al., 1997). However, TL is highly variable across different
species (Table 1.1).
Table 1.1 - Telomere length variation across vertebrate species
Vertebrate species
Human
Dogs
Birds
Rats
Mice

Telomere length
5-15kb
12-23kb
5-20kb
20-100kb
Up to 150kb

Reference
(Moyzis et al., 1988)
(Nasir et al., 2001)
(Haussmann et al., 2003)
(Cherif et al., 2003)
(Hemann and Greider, 2000)
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Figure 1.1 - Telomeres are located at the ends of linear DNA
Telomeres are located at the ends of linear chromosomal DNA consisting of repetitive
units of TTAGGG in vertebrates.
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1.2.1

T-Loop

The 3’ overhang of telomere forms the secondary structure, which varies between taxa.
In vertebrates it forms a T-loop structure and internal D-loop (Figure 1.2) by looping
around to invade upstream telomeric DNA (de Lange, 2005). The 3’overhang is
maintained during each round of DNA replication by a nuclease called Apollo (Wu et al.,
2010). T-loop size is proportional to TL (Rahman et al., 2008). In fact, mice T-loop size
is 18 kb long, whereas in humans it is only 3 kb (Griffith et al., 1999), reflective of their
differing TLs (20-80 kb versus 10-15 kb, respectively) (Kipling and Cooke, 1990;
Zijlmans et al., 1997).

1.2.2

Shelterin

Telomeres are further stabilized by a protein complex called shelterin (de Lange, 2005).
Shelterin is composed of six proteins (Figure 1.2) – telomeric repeat binding factor 1 and
2 (TRF1 and TRF2), protection of telomeres 1 (POT1), repressor/activator protein 1
(Rap1), POT1-TIN2 organizing protein (TPP1, also referred to as TINT1, PIP1, and
PTOP), and TRF1-interacting protein 2 (TIN2). Three of these proteins (TRF1, TRF2,
and POT1) bind directly to telomeric repeats. TRF1 and TRF2 bind to double-stranded
repeats via their SANT/Myb domains with high specificity and affinity and each have a
flexible hinge that enables the formation of the T-loop (de Lange, 2005; Diotti and
Loayza, 2011). POT1 binds directly to the single-stranded 3’overhang via its OB folds,
which is important in the formation of the D-loop (Baumann and Cech, 2001; de Lange,
2005; Lei et al., 2004; Palm and de Lange, 2008). Unlike human cells that have only one
POT1 gene, mice have two variants that are highly homologous (POT1a and POT1b) but
have distinct roles at telomeres (He et al., 2006; Hockemeyer et al., 2006). The other
three proteins (Rap1, TPP1, and TIN2) are recruited by TRF1 and TRF2 to assist in
stabilizing telomeres (de Lange, 2005). TIN2 acts as the bridge between different
shelterin components by binding TRF1 and TRF2 in separate domains and recruiting the
TPP1-POT1 complex (Chen et al., 2008; Kim et al., 2004; Liu et al., 2004; Ye et al.,
2004). Furthermore, a novel isoform of TIN2 (TIN2L) tethers telomeres to the nuclear
matrix (Kaminker et al., 2009), which may play a role in chromosome stability.

4

Figure 1.2 - Secondary structure of telomeres.
Protein components of shelterin complex are involved in the formation and stability of Tloop and internal D-loop secondary structures of telomeres. Image modified from
(Oeseburg et al., 2010).
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TPP1 binds TIN2 and POT1 in separate domains and is thought to be central in recruiting
POT1 to telomeres (Chen et al., 2007; Kibe et al., 2010). Lastly, Rap1 is recruited by
TRF2 and forms a tightly associated complex that is essential for Rap1’s binding to
telomeres (Celli and de Lange, 2005; Li and de Lange, 2003; Li et al., 2000). Overall
the shelterin complex is involved in telomere stability and telomere length regulation (de
Lange, 2005).

Telomere function

1.3

Telomeres are considered as a telomeric cap because of the important functions it serves
for linear DNA. Over the years scientists have uncovered that telomeres play a
fundamental role in the stability and mobility of the genome and prevent erosion of
coding DNA.

1.3.1

Genomic stability

The chromosome ends were first proposed to be important for chromosome stability by
the combined work of Barbara MClintock and Hermann Muller on their work with maize
and fruit flies, respectively (McClintock, 1939; Muller, 1938). Muller coined the term
telomere from the greek words telos (end) and meros (part). Both scientists observed that
without telomeres, chromosomes would fuse together and break off during mitosis
(Figure 1.3), which was catastrophic to cellular physiology.
Telomere dysfunction either by critically shortened telomeres or missing shelterin
components can activate the DNA damage response (DDR) and signal up-regulation of
cell cycle checkpoints such as p53 (Bodnar et al., 1998; Karlseder et al., 1999; Lee et al.,
1998). In some cells, cell cycle checkpoints can be by passed, propagating breakage
fusion bridge cycles and genomic rearrangements with risk of neoplastic transformation
(Figure 1.3). Thus cells require telomeres as a way to protect natural ends from being
recognized as double strand breaks, in order to suppress the DNA repair machinery and
maintain genomic stability (Chan and Blackburn, 2004).

6

Figure 1.3 - Anaphase breakage fusion bridge cycles
Without telomeres (yellow circles) at the ends of chromosomes, a fusion event can take
place between bare ends. During anaphase when chromosomes are pulled to opposite
poles of the cell, DNA will break between bridged chromosomes. Anaphase breakagefusion-bridge cycles cause genomic shuffling (amplifications and deletion events) and
instability that can lead to further complications of cancer. Image modified from (Else,
2009).
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Furthermore, during meiosis telomeres form bouquet structures that are integral to the
coordination of the spindle apparatus to ensure proper alignment and segregation of
genetic material (Maddar et al., 2001; Tomita and Cooper, 2007).

1.3.2

End-replication problem

One of the most important functions of telomeres was discovered by Olovnikov and
Watson who noticed that linear chromosomes cannot replicate their very ends, termed the
“end-replication problem” (Olovnikov, 1973; Watson, 1972). The end-replication
problem leads to inevitable loss of telomeres at every cell division. DNA polymerase can
only replicate in the 5’ to 3’ direction and requires a short RNA primer for initiation
(Shore and Bianchi, 2009). Because DNA is double stranded, one strand will be
synthesized in short “okazaki” fragments. However, at the 5’ end of the lagging strand,
there will be a gap due to removal of the last RNA primer (Shore and Bianchi, 2009).
Currently, it is not known whether or not the last RNA primer is placed at the very end of
telomeres or is variable (Sfeir et al., 2005b). Telomere ends undergo further processing
following DNA replication to ensure there is a 3’ overhang with a precise end sequence
(Sfeir et al., 2005a). Interestingly, the length of this overhang is highly variable between
different cell types and is closely associated with telomere length (Lee et al., 2008).
Initially, cells were thought to lose telomeres at a constant rate, keeping track of the
number of cell divisions like a “mitotic clock” (Von Zglinicki, 2003). However, there is
considerable heterogeneity in the rate of telomere shortening (Martin-Ruiz et al., 2004)
and in the number of divisions a cell can undergo (Hayflick, 2003; Smith and Hayflick,
1974). Notably, the end-replication problem directly limits the number of possible cell
divisions (Olovnikov, 1973), later known as replicative senescence.

1.4

Telomeres and cell senescence

There are several ways in which cells senesce but one of the main mechanisms is
telomere shortening and dysfunction, specifically referred to as replicative senescence or
mortality 1 (M1) senescence (Harley et al., 1990). During each round of cell division,
telomeres shorten by ~50-200 bp due to oxidative stress and the end replication problem
– where DNA polymerase cannot replicate the very ends of the lagging strand
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(Blackburn, 2005; Vaziri et al., 1994). In cells, this shortening eventually causes
telomeres to reach a critical length (“Hayflick limit”) that signals a DNA-damage
response (DDR), which involves protein kinases (ATM and CHK2), adaptor proteins
(53BP1 and MDC1) and chromatin modifiers (γ-H2AX) (Campisi and d'Adda di
Fagagna, 2007). Telomere dysfunction induced foci (TIF), defined as cells with more
than 50% of 53BP1 foci colocalised with telomere repeats, are often used to identify
telomere-dependent senescent cells (Jeyapalan et al., 2007). Telomere-dependent
activation of DDR further leads to the activation of p53 via its phosphorylation and
upregulation of its downstream target p21 (Blackburn, 2005; Campisi and d'Adda di
Fagagna, 2007; Hornsby, 2002). Expression of p21 maintains pRB in a
hypophosphorylated active state, which inactivates the transcriptional factor E2F. E2F is
responsible for inducing the expression of genes that encode proteins responsible for cellcycle progression (i.e. replication-dependent histones, c-FOS, cyclin A and B, and
proliferation cell nuclear antigen (PCNA)). Therefore, repressing E2F activity causes
cells to enter a state of permanent cell cycle arrest (senescence) (Blackburn, 2005;
Campisi and d'Adda di Fagagna, 2007; Hornsby, 2002). If any of these cell cycle
checkpoints are by-passed (most commonly p53), perhaps due to mutations, the cell will
continue to divide and telomeres will continue to shorten until a crisis phase (M2 phase)
is reached. In M2 phase, telomeres are virtually non-existent and chromosome fusion
events occur due to activation of the non-homologous end joining (NHEJ) pathway,
which can result in genomic shuffling as shown in Figure 1.3 (Shay and Wright, 2005).
One of the key factors in triggering senescence or apoptosis in aging cells is shortened
telomeres that can no longer form a closed t-loop. In fact, inhibition of TRF2 from
shelterin in vitro causes the activation of DDR and senescence (Celli and de Lange, 2005;
Takai et al., 2003). In a similar way, human cells transfected with short telomere
oligonucleotides that mimic the effect of an open t-loop also trigger a p53 dependent cell
cycle arrest (Saretzki et al., 1999).
It is noteworthy that cellular senescence can also be induced by telomere-independent
mechanisms such as damage induced by reactive oxygen species (ROS), which follows
an alternate senescence pathway through the upregulation of p16 and pRB (Finkel and
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Holbrook, 2000). Murine fibroblasts in culture will senesce after 15-20 population
doublings despite having exceptionally long telomeres (>20 kb) when exposed to
atmospheric oxygen concentrations of 20%, which is above biological levels of 3%
(Hornsby, 2003; Parrinello et al., 2003). In contrast, human fibroblasts with shorter
telomeres (10-15 kb) senesce between 50-60 population doublings, suggesting better
protective mechanisms against ROS compared to mouse cells (Hornsby, 2003; Parrinello
et al., 2003). To some degree this argues against the relationship between telomere
shortening and aging, particularly in mice, however, in vitro studies do not fully translate
in vivo (Varela et al., 2011). Furthermore, the shortest mice telomeres are just as short to
those in human cells (Zijlmans et al., 1997), and a single short telomere is sufficient to set
off the cascade of events leading to senescence (Abdallah et al., 2009; Bendix et al.,
2010). Finally, it is not known whether the threshold telomere length that induces
senescence in humans and in mice is different. Perhaps in mice that have an average Tloop size 6-7 times greater than in humans (Rahman et al., 2008), require longer
telomeres to maintain a closed T-loop structure.

1.5

Cellular senescence and aging

Cellular senescence describes a cell that has undergone permanent cell cycle arrest and
ceased to divide. This phenomenon was first observed in 1961 by Leonard Hayflick, who
observed that primary human fibroblasts in culture can only divide a limited number of
times (40-60 population doublings (PD)), later referred to as the “Hayflick limit”
(Hayflick, 1965; Hayflick and Moorhead, 1961). The exact number of divisions a cell
can undergo is dependent on cell type and organism (Campisi and d'Adda di Fagagna,
2007). For instance, stem cells and cancer cells can divide indefinitely in culture,
whereas human somatic cells cannot (Itahana et al., 2004). However, murine somatic
cells senesce between 15 and 20 PDs and can immortalize spontaneously in culture
(Itahana et al., 2004). A senescent cell is characterized by a flattened morphology in 2D
culture, altered gene expression, and secretion of various matrix-degrading enzymes
(Campisi and d'Adda di Fagagna, 2007).
Cellular senescence is considered both beneficial to young organisms and harmful to old
ones, a term referred to as antagonistic pleiotropy (Figure 1.4) (Jeyapalan et al., 2007).
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Figure 1.4 - Antagonistic pleiotropy of senescent cells in young and old individuals
Young tissue is predominantly composed of normal, healthy, fully-functional cells.
Whenever stress on a cell is too great or telomeres are too short, the cell undergoes
apoptosis or senescence to avoid tumorigenesis. However, as we age, old tissue is
burdened by an accumulation of senescent cells, compromising tissue function. What
was protective at a young age against tumors is destructive to old organisms leading to
age-related pathologies. Image modified from (Chuaire-Noack et al., 2010).
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In young organisms cellular senescence is said to have evolved as a tumor suppressor by
giving highly proliferative cells a limited capacity to divide. In older organisms,
senescent cells tend to accumulate in organs, leading to age-related phenotypes
(Jeyapalan et al., 2007).
Evidence begins to accumulate that supports the link between cellular senescence and
organismal aging. First, the number of senescent cells increases with age and appears to
be rare in young individuals (Dimri et al., 1995; Jeyapalan et al., 2007). Furthermore,
sites of age-related pathologies such as atherosclerosis and osteoporosis contain increased
number of senescent cells (Chang and Harley, 1995; Price et al., 2002; Vasile et al.,
2001). Moreover, the altered secretory profile (upregulation of matrix degrading
enzymes, growth factors, and pro-inflammatory cytokines) of senescent cells has
detrimental impacts on neighboring cells and structural components of tissue that lead to
aged and diseased pathologies (Burton, 2009). Taken together, evidence suggests burden
of senescent cells is connected to organismal senescence. Since telomere length is
considered an endogenous marker of cellular senescence, its length is also a putative
marker of biological aging.

1.6

Telomere length (TL) regulation

TL equilibrium is established by the net result of telomere shortening and lengthening
events. The frequency of each of these events varies depending on the cell type and
organism involved (Shay and Wright, 2007). Several of the key factors that influence
telomere length dynamics in a cell are outlined in Figure 1.5.

1.6.1

Factors that cause telomere shortening

There are several factors that cause telomere shortening in a cell as listed in Figure 1.5.
The two most common causes are due to the end-replication problem, discussed in
section 1.3.2, and oxidative damage to DNA.
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Figure 1.5 - Factors affecting telomere length dynamics in vertebrate cells
During DNA replication telomeres are in an open structure to allow DNA polymerase to
extend the entire length of the chromosome. However, various factors contribute to
telomere shortening that are propagated during replication such as the end-replication
problem, oxidative DNA damage, replication errors, and telomere trimming. As cells
divide and telomeres reach a critical length, they can no longer form a closed t-loop
structure which signals cell cycle checkpoints such as ATM, ATR and p53, causing cells
to enter a state of senescence or apoptosis. Telomere lengthening mechanisms, such as
telomerase and alternative lengthening of telomeres can extend the replicative capacity of
cells by lengthening their telomeres. Image modified from (Aubert and Lansdorp, 2008).

13

1.6.1.1

Oxidative DNA damage

While the end-replication problem sets the baseline of telomere shortening, oxidative
stress is the best recognized modifier. The minimal rate of telomere shortening observed
in culture is 10-20 bp per cell division in fibroblasts with high antioxidant capacity (Serra
et al., 2003; von Zglinicki, 2002) or those treated with an agent that reduces oxidative
stress in cells (Passos et al., 2007). This lower rate of attrition is likely that set by the
end-replication problem, which differs significantly from the average rate of telomere
attrition in human cells (50-200 bp). This difference is primarily due to oxidative stress
(von Zglinicki et al., 2000).
The major source of reactive oxygen species (ROS) in cells comes from mitochondria, as
a metabolic by-product. Burden of ROS in a cell induces various types of DNA damage
(oxidized bases, single and double strand breaks), which accumulates over time (Fraga et
al., 1990; Packer and Fuehr, 1977). Telomere shortening is largely accelerated by
accumulation of oxidative DNA damage; in particular, by single strand breaks (von
Zglinicki et al., 2000; von Zglinicki and Schewe, 1995). Those damages that are not
repaired or replaced before the next round of DNA replication will be lost due to stalling
of the replication fork. Therefore, telomere loss due to oxidative damage is dependent on
DNA replication (von Zglinicki, 2002).
Cells engage antioxidant defenses to protect against the harmful effects of oxidative
stress by neutralizing free radicals (von Zglinicki, 2002). The strength of these defenses
varies between cell types and species. Some strains of human fibroblasts have higher
antioxidant levels than others, reflective in lower telomere attrition rates (von Zglinicki,
2002). As mentioned in section 1.4, mouse cells are more prone to oxidative damage
than human cells (Hornsby, 2003). Replicative lifespan can be extended and telomere
shortening reduced by increasing the expression of antioxidant enzymes (Furumoto et al.,
1998; Serra et al., 2003). In contrast, cell lifespan can be decreased by increasing
oxidative stress or inhibition of antioxidant defenses (Kurz et al., 2004; Passos et al.,
2007). The degree of damage at a given level of oxidative stress is highly variable
simply due to chance, which may explain differential rates of telomere shortening

14

observed between populations of cell clones in vitro and between individuals in vivo
(Von Zglinicki, 2003).
Telomeres are particularly sensitive to oxidative damage compared to other parts of the
genome due to the presence of guanine triplet base pairs (GGG), which are major targets
of ROS (Kruk et al., 1995; Oikawa et al., 2001; Petersen et al., 1998). In fact, human
telomeres showed 7 times more DNA breaks than control sequences when inserted into a
plasmid (Henle et al., 1999). Moreover, repair of damage at telomeres is significantly
less efficient than the rest of the genome, even compared to guanine-rich interstitial
sequences (Petersen et al., 1998). Therefore, telomeres contain a greater degree of
oxidative damage upon initiation of DNA replication than the bulk of the genome,
contributing significantly to their attrition (von Zglinicki et al., 1995). In fact, the
frequency of single-stranded breaks is directly proportional to the amount of telomere
loss at replication (Sitte et al., 1998). One theory for this increased damage at telomeres
is an evolutionary role as sentinels to detect levels of DNA damage procured by the cell
and shut it down before they become dangerously high (von Zglinicki et al., 2000).

1.6.1.2

Other factors that contribute to telomere shortening

Telomere shortening can be caused by DNA replication errors caused by mutations or
malfunction of various proteins such as RecQ protein-like helicases (WRN and BML)
and RTEL (Crabbe et al., 2004; Machwe et al., 2011; Sidorova, 2008; Uringa et al.,
2011). These helicases function in the resolution of higher order telomeric structures (Gquadruplexes and t-loop) to allow for efficient replication of telomeres and prevent
stalling of the replication fork (Machwe et al., 2011; Postberg et al., 2012).
A recently discovered and less understood mechanism of telomere shortening is called
telomere trimming, which involves resolution of t-loops from telomeres by
recombination. This mechanism has been observed in human and mouse cells and is
believed to set an upper limit on telomere length and contribute to a length equilibrium
set-point (Pickett and Reddel, 2012).
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1.6.2

Factors involved in telomere length maintenance

The progressive attrition of telomeres caused by the end-replication problem and
oxidative damage posed a problem for certain cell types, especially in the germ line. If
telomeres continue to shorten across generations, species with linear chromosomes
(eukaryotes) would soon become extinct. Cells had to develop ways to overcome this
problem by mechanisms of telomere lengthening. The most common method,
discovered by Nobel Prize laureates Dr. Elizabeth Blackburn and Dr. Carole Greider, is
by the activity of a reverse transcriptase called telomerase (Greider and Blackburn, 1985,
1987). A second, less common method, alternative lengthening of telomeres (ALT), was
discovered in telomerase negative cancer cells (Bryan and Reddel, 1997; Reddel et al.,
1997).

1.6.2.1

Telomerase

Telomerase exists to circumvent the end-replication problem by catalyzing the addition
of telomeric repeats de novo to the ends of DNA (Blackburn, 2005). Telomerase is a
ribonucleoprotein composed of a core reverse transcriptase (TERT) and an RNA
component (TERC), which acts as a template for addition of telomeric repeats to the 3’
end of telomeres (Figure 1.6) (Blackburn, 2005).
Proper folding and stability of TERC is orchestrated by the nucleolar enzyme dyskerin
(DKC1 gene) (Gu et al., 2009). Both components of telomerase are expressed at low
levels, giving rise to clinical problems by haploinsufficiency in either TERT or TERC
(Du et al., 2007; Mason and Bessler, 2004), or mutations in DKC1 (Mason et al., 2005).
Expression and activity of telomerase are highly regulated at various levels, which
include transcription, splicing, post-translational modifications, assembly, and subcellular localization (Gladych et al., 2011; Wojtyla et al., 2011).
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Figure 1.6 - Elongation of telomeres by telomerase
Telomerase adds repeats six nucleotides at a time in three distinct steps that involve
substrate recognition and binding, elongation, and translocation or dissociation from
telomere ends. Image modified from (Nicholls et al., 2011)
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Many proteins function in concert to orchestrate recruitment of telomerase, telomere
length itself being a signal. In fact, telomerase preferentially elongates the shortest
telomeres (Britt-Compton et al., 2009), which seems to be a function of shelterin proteins
(Wojtyla et al., 2011). Longer telomeres contain more shelterin proteins, which represses
access of telomerase to telomere ends. However, the rate of telomere elongation by
telomerase can be increased by inhibition of various shelterin components, such as POT1
or TRF1 (Wojtyla et al., 2011). The dynamics of telomerase repression and recruitment
are intricate and change in different conditions. In fact, the interplay between POT1 and
TPP1 acts both as a repressor of telomerase in one condition and a processivity factor in
another (Wang et al., 2007). Furthermore, a novel protein (MOV10 helicase) was
discovered that binds to both TERT and telomeric DNA. MOV10 is expressed
exclusively in human testis and ovaries, and is thought to maintain telomerase activity in
those tissues (Nakano et al., 2009).
Telomerase expression is ubiquitous in the developing embryo (Wright et al., 1996).
However, during somatic differentiation telomerase is down-regulated, which is
considered to have evolved as an anti-tumorigenesis mechanism (Forsyth et al., 2002). In
this way, somatic cells do not retain capacity to divide indefinitely. Conversely, stem
cells and germ cells maintain a degree of telomerase activity, which is highest in testes
(Blackburn, 2005). This is vital so that telomere loss is not passed on to offsprings
(Schaetzlein et al., 2004). Nonetheless, even somatic stem cells show telomere
shortening with age with increased demand to replenish aging cells in tissue (Allsopp et
al., 2001; Vaziri et al., 1994).
Telomerase expression in somatic cells also varies between species. Mice continue to
express telomerase to some degree in somatic tissues (Prowse and Greider, 1995),
whereas humans do not (Kim et al., 1994). Furthermore, recent evidence suggests that
decreased somatic telomerase expression correlates with increased body size of a species
(Gomes et al., 2011), proposing an evolutionary mechanism to offset the increased risk of
cancer due to increased body mass (Gorbunova and Seluanov, 2009; Seluanov et al.,
2007).
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Ultimately, telomerase expression is highly associated with risk of cancer as expressed in
over 85% of human cancers (Kim et al., 1994). Therefore, there is a trade-off between
replicative capacity and risk of cancer in the regulation of telomerase activity, which
varies between species and cell types.

1.6.2.2

Alternative lengthening of telomeres (ALT)

Alternative lengthening of telomeres involves a recombination based mechanism that is
used in 15% of cancer cells lacking telomerase (Bryan and Reddel, 1997). However,
anti-telomerase treatment of cancer can provoke the use of ALT (Hu et al., 2012). Two
characteristic features used to detect ALT cells are the formation of ALT-associated
promyelocytic leukaemia (PML) body (ABP) and long and heterogeneous telomeres
(Nabetani and Ishikawa, 2011).
PML body is a nuclear aggregate of PML and other proteins, which is present in many
cell types and functions in various cellular processes (stress response, tumour formation,
DNA repair, etc.). However, APB’s are special as they include telomere DNA and
chromatin, which can be readily observed (Yeager et al., 1999). The molecular
mechanism of PML and how APB’s are related to the ALT pathway is currently
unknown. However, many proteins involved in metabolism, cell growth regulation, and
particularly homologous recombination localize at APB. RecQ-like DNA helicase BLM
is an APB protein that is required for growth of ALT cells (Bhattacharyya et al., 2009),
whereas WRN appears dispensable (Laud et al., 2005). The MRN complex and shelterin
components are also important for the formation of APB and maintenance of telomeres
by the ALT pathway (Nabetani and Ishikawa, 2011).
The long and heterogeneous nature of telomeres in ALT cells represents the critical
difference between ALT- and telomerase-dependent telomere lengthening. First, mean
telomere length of ALT cells is ~20 kb compared to <10 kb in telomerase-positive cells
(Bryan et al., 1995). Second, analysis of metaphase spreads by qFISH (discussed in
section 1.7.2) revealed large variations in telomere signal between chromosome arms in
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ALT cells in comparison to telomerase-positive cells (Perrem et al., 2001). Studies
using tagged telomeres support a recombination based mechanism based on observations
of telomere duplication from one chromosome to the next, as well as drastic elongation
and deletion events (Dunham et al., 2000; Murnane et al., 1994). Moreover, high levels
of telomere-sister-chromatid exchange (T-SCE) was observed in ALT cells but not
telomerase-positive cells (Bailey et al., 2004; Bechter et al., 2004; Londono-Vallejo et al.,
2004).
ALT cells also contain extrachromosomal telomere repeat (ECTR) in the form of
telomeric circles (t-circles), determined by 2D gel electrophoresis (Cesare and Griffith,
2004; Wang et al., 2004). However, t-circles can also be observed in cells with defects in
TRF2 or cells containing extensively long telomeres, such as Mus musculus mice (Pickett
et al., 2009). T-circles are formed by resolution of the t-loop structure by intrachromosomal recombination events, termed telomere trimming (section 1.6.1.2). Several
mechanisms of recombination are proposed to be used by the ALT pathway (Figure 1.7).
Unlike break induced replication (BIR) and rolling-circle replication (RCR), integration
of t-circles into chromosome ends do not cause an increase in total cellular telomeric
repeats (Nabetani and Ishikawa, 2011). RCR is probably the most efficient
recombination method of lengthening telomeric ends and can cause drastic telomere
lengthening. BIR and RCR are not exclusive of each other and are likely governed by the
same molecular mechanisms (Nabetani and Ishikawa, 2011).
Currently, little evidence suggests that non-neoplastic cells use the ALT pathway to
maintain their telomeres. However, one study provides evidence that ALT may occur in
endothelial, stromal and some epithelial cells upon acquisition of sufficient DNA damage
(Slatter et al., 2012). Nonetheless, telomerase is the dominant mechanism when it comes
to maintenance of telomeres in all cell types.
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Figure 1.7 - Mechanisms of alternative lengthening of telomeres
Recombination in ALT cells may occur by intra-chromosomal recombination causing
drastic telomere shortening as seen by the formation of T-circles. Lengthening by
recombination can occur by three possible mechanisms: (A) invasion of chromosome
ends to induce break-induced replication, (B) integration of a T-circle into a chromosome
end, and (C) rolling-circle replication initiated by the 3’overhang invading proximal Tcircles. Image modified from (Nabetani and Ishikawa, 2011)
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1.7

Telomere length measurement

Several methods of measuring telomere lengths have been developed over the years, each
with their individual caveats (Aubert et al., 2012; Lin and Yan, 2005). The main two
groups of measurements are those that measure average telomere length (TRF and qPCR)
and those that measure telomere lengths of individual chromosomes (Q-FISH, FlowFISH, and STELA). All methods use binding of nucleic acid probes or primers specific
to telomeric repeats. Discrepancies between telomere length measurements of the
various methods arise from variability in the amount of extra-telomeric region (Figure
1.8) included in some techniques and less in others (Aubert et al., 2012). The two most
popular methods in the literature are telomere restriction fragment (TRF) analysis and
quantitative polymerase chain reaction (qPCR).

1.7.1

TRF analysis

TRF analysis by southern blotting was the first method to be described (Harley et al.,
1990) and represents the gold standard used to validate all other techniques to date
(Aubert et al., 2012; Kimura et al., 2010b; Lin and Yan, 2005). This technique uses a
pair of frequent cutting restriction enzymes (i.e. Hinf1 and Rsa1) to cut DNA into small
fragments, specifically excluding telomeric repeats as substrates. Frequent cutting
restriction enzymes are used to minimize the size and variation of extra-telomeric region
(Figure 1.8). The fragmented DNA is then separated by agarose gel electrophoresis,
transferred to a nitrocellulose or nylon gel and hybridized with a radioactive ( 32P) or
chemiluminescent (digoxienin) labeled probe complementary to telomere sequences.
Average telomere length of the resulting smear is estimated based on a DNA ladder and
normalization to a reference sample to correct for inter-experimental gel effect. The
length and intensity of the smear needs to be accounted for in the calculation of average
telomere length. Although this is a well established technique, variations between studies
have procured over time because the technique was not standardized in terms of
restriction enzymes used, DNA quantity and quality, and blot analysis. There are several
main pitfalls to this method. First, a relatively large amount of pure and unfragmented
DNA (0.5-10 µg) is required and small differences in telomere lengths are difficult to
detect, which limits its use to broad research questions.
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Figure 1.8 - Detection of extra-telomeric DNA with different methods of telomere
length measurement
In Figure 1.8 modified from (Aubert et al., 2012), extra-chromosomal region is described
as the proportion of DNA that is not considered pure telomere repeats (blue bars). In
gold is the subtelomere region that contains restriction enzyme sites (dashed lines) used
to digest DNA in TRF analysis. In red are the variant repeats that contain telomere-like
sequences. The green box for STELA is the primer used in the subtelomeric portion that
is later subtracted from the calculation of telomere repeats. The light blue boxes are
regions that have variable detection.
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Furthermore, TRF analysis is time consuming (5-7 days), making it less ideal for large
clinical studies, although skilled technicians can process up to 130 samples per week
(Kimura et al., 2010b). Lastly, large variations in telomere length (up to 5%) can be seen
depending on the choice of restriction enzymes used and because of subtelomeric
polymorphisms. However, despite limitations of this technique, the errors of this method
are relatively small (CV=1.74%) (Aviv et al., 2011).

1.7.2

qFISH

Telomere length can also be measured by quantitative fluorescence in situ hybridization
(qFISH), which combines use of image cytometry and metaphase spreads through use of
peptide nucleic acid (PNA) probes (Aubert et al., 2012; Martens et al., 1998; Poon and
Lansdorp, 2001). These probes have a greater affinity than DNA oligonucleotides and
bind specifically to denatured telomere repeats. The fluorescent signal is acquired using
specific qFISH analysis software and telomere lengths are measured relative to standards
of known length. Karyotyping of metaphase spreads allows telomere lengths to be
matched with its corresponding chromosome arm. It’s the method of choice to determine
telomere length of specific chromosome ends. The analysis requires 15-20 metaphases
per sample to obtain reliable results due to the high variation in the technique. Some
advantages are that qFISH can detect chromosome fusion events and ends with virtually
no repeats (<0.5 kb). This technique is a good choice to study telomere biology in rare
cell types and can be used to ask more specific scientific questions because it requires so
few cells. However, some disadvantages are that qFISH cannot be used to measure
telomeres in cells that cannot divide such as senescent cells and highly aberrant cells.
Furthermore, the technique is labor intensive and takes a long time, and requires
specialized equipment.

1.7.3

Flow-FISH

Similar to qFISH, flow-FISH also uses PNA probes, however hybridization is done with
cells in suspension and median telomere length of individual cells is measured using flow
cytometry (Aubert et al., 2012; Martens et al., 2000). This technique can be used to
measure telomere lengths of specific cell populations (i.e. granulocytes and lymphocytes)
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in a single sample by cell sorting prior to flow-fish or staining for antibodies (limited to a
few cell surface markers that are retained after hybridization). A semi-automated
adaptation of this technique uses a 96-well plate and robotic microdispenser to reduce
tedious work and increase reproducibility. It is currently the method of choice for
measuring telomere length in specific subsets of blood cells. Some drawbacks of this
technique are that it requires a suspension of living cells, which is very fragile. This
technique is generally limited to use of fresh blood. Like qFISH this method requires
specialized equipment, is technically challenging and costly (Aubert et al., 2012; Martens
et al., 2000).

1.7.4

STELA

One of the newest techniques available is Single Telomere Length Analysis (STELA),
which uses PCR to amplify a specific chromosome arm of telomere (Aubert et al., 2012;
Baird et al., 2003). STELA takes advantage of the fact that all chromosome arms end in
a 3’ overhang, which is targeted as a template to anneal an oligonucleotide linker at the 5’
end of the telomere. A linker-specific primer and subtelomere specific primer is then
used to amplify a precise length of a single telomere tract. PCR amplicons are then
separated by gel electrophoresis, southern blotting and probed with specific subtelomere
sequences. Resulting banding patterns are intricate sets of discrete bands of individual
telomeres, which can be measured individually or pooled based on size according to a
DNA ladder of known lengths. One drawback of STELA is its limitation to well
characterized chromosome arms (XpYp, 2p, 11q, 12q and 17p) (Britt-Compton et al.,
2006) because not all chromosomes have adequate sequences for the design of unique
chromosome primers. Therefore, caution must be taken when analyzing results because a
subset of telomere measurements may not be reflective of the overall telomere status of
cells (Bendix et al., 2010). Although no specialized equipment is required, STELA is
technically challenging and requires intensive initial preparation and optimization (Baird
et al., 2003). Furthermore, STELA has an upper detection limit of 20kb, which limits its
use mostly to human samples, and it cannot be used on model organisms with long
telomeres such as Mus musculus strains of mice (Kipling and Cooke, 1990). Benefits of
STELA are in its precision of telomere length measurement, its ability to detect subtle
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changes in telomere length, and minimal starting material required (as few as 50 cells) to
produce reliable results (Aubert et al., 2012). Like qFISH, STELA is well fit to study
telomere lengths in rare cell populations, and it can also detect short telomere outliers,
those responsible for chromosome fusion and senescence.

1.7.5

qPCR

QPCR based telomere length measurement (Cawthon, 2002) has become widely used in
large clinical and epidemiological studies because of its rapid design, ease of use, and
low cost. This technique relies on specific amplification of telomeric repeats (T)
normalized to a single-copy gene (S) to produce an average telomere length (T/S ratio).
A sample calculation can be viewed in appendix B. A special set of telomere specific
primers were designed that contain mismatches every six base pairs, different in both the
forward and reverse primer. These mismatches are important to minimize primer dimer
formation and maximize primer-template hybridization. Telomere-specific primers bind
along telomeric repeats at each chromosome arm and amplify in fragments of at least 76
bp and up to ~500 bp long. SYBR green, a dye that fluoresces upon binding to double
stranded DNA, is used to monitor the amplification of DNA using Real-Time PCR. The
longer the average telomeres are in a given sample, the greater the fluorescent signal.
A setback of qPCR is in the variability between experiments. Proper controls are
required to minimize this variability. In every experiment, a set of inter-plate control
samples and a standard curve must be produced to offset the variability (Aubert et al.,
2012; Aviv et al., 2011). An important quality control of this technique is in the
preparation of DNA samples. It is critical that all DNA samples are of equivalent quality
so that there are no variations in amplification efficiencies. Another drawback of this
technique is that it is not standardized across different laboratories, and therefore results
between laboratories cannot be compared. A multiplex version of this technique has
recently been developed (Cawthon, 2009) that further reduces variation, which amplifies
telomere repeats and single-copy-gene in the same PCR reaction. Although qPCR
technique is prone to variation, with proper controls it can produce quick and reliable
results at a low cost, which is beneficial for most large-scale experimental designs.
Furthermore, an impartial analysis between laboratories comparing TRF analysis and
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qPCR analysis on the same set of DNA samples revealed a strong correlation between
both techniques, although TRF had slightly better inter-assay variation (Aviv et al.,
2011).
Choosing the proper technique depends solely on the experimental design and scientific
question being asked, as each technique has its advantages and disadvantages.

Telomere dynamics in the aging population

1.8

There are key differences between human and mouse telomere biology (Table 1.2). How
these differences relate in vivo to consequences in telomere length shortening with age
and disease are currently not fully understood. However, genetically modified mice have
been useful to elucidate the role telomeres play in aging and chronic illness. Key
findings that link telomere biology to cardiovascular disease and cancer are further
discussed below.
Table 1.2 - Differences between mouse and human telomere length dynamics
Phenotype

Mice

Humans

Reference

Inter-chromosomal
variation in telomere
length

Mus musculus (20-150
kb); CAST/Ei (15-20 kb)

5-15 kb

(Hemann and
Greider, 2000;
Zijlmans et al.,
1997)

T-loop size

~18 kb

~3 kb

(Griffith et al., 1999)

Telomerase activity

Low levels in adult
somatic cells

Absent in adult
somatic cells

(Prowse and
Greider, 1995)

T-circles

High frequency

Low frequency

(Pickett et al., 2011)

Mus spretus (15-20 kb)

-

Immortalization in
culture

Spontaneous

Rare, 1 in 10E 7

(Wright and Shay,
2000)

Telomerase
processivity

Non-processive (1-2
repeats)

Processive (long
tracts)

(Prowse et al.,
1993)

1.8.1

Telomere length with age

Several studies have documented telomere length shortening with age in various tissue or
cell types both in vivo and in vitro. The concept of telomeres as a mitotic clock came
from in vitro studies, whereby fibroblasts, lymphocytes and hematopoietic stem cells
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(HSCs) lose between 37 and 120 bp per population doubling (Harley et al., 1990; Vaziri
et al., 1994; Vaziri et al., 1993). However, unlike human primary fibroblasts, mouse
embryonic fibroblasts in culture do not show obvious telomere shortening with age,
likely attributed to telomerase activity present in cultured mouse cells (Sachsinger et al.,
2001). In telomerase knockout mice (TERT-/- or TERC-/-), telomeres do in fact shorten
in culture. Furthermore, by inducing expression of the catalytic subunit of telomerase
(TERT) in vitro to human differentiated cells, telomere length is maintained and
replicative senescence postponed (Bodnar et al., 1998; Ramirez et al., 2001; Yang et al.,
1999). One group studied telomere attrition in 14 different tissues of a large human
population ranging from 0 to 104 years of age. They reveal a significant reduction in
telomere length with age in all tissues studied except cerebral cortex and myocardium,
thought to be due to the quiescent nature of cells in those tissues (Takubo et al., 2002). In
mice, telomere length attrition has also been shown in several tissue types with age,
including spleen, skin, small intestine and brain (Coviello-McLaughlin and Prowse,
1997; Flores et al., 2008). Telomere loss per year in vivo for most tissues appears to be
within the range of telomere loss of one cell division in vitro. However, these results are
likely skewed by telomere length maintenance and heterogeneity in cell or tissue types
(Takubo et al., 2002). Several studies have calculated an average telomere shortening
rate in lymphocytes (53 bp/year), granulocytes (39 bp/year) (Hoffmann et al., 2009), and
pancreas (36 bp/year) (Ishii et al., 2006).
Telomere length attrition rates vary with age, showing a biphasic pattern in lymphocytes
(Frenck et al., 1998; Rufer et al., 1999). Most telomere shortening tends to happen in the
first few years of life, gradual shortening during adulthood, and accelerated shortening in
old age. From birth to age 4, an average telomere loss of 1kb is seen and thereafter
telomeres shorten by 100bp/year (Frenck et al., 1998). In specific subsets of blood cells,
Rufer et al. determined that 1.08kb of telomere sequence was lost in lymphocytes within
the first 1.5years, and 3.05kb loss in granulocytes in the first 0.5year of life (Rufer et al.,
1999). There are no gender differences in telomere length at birth in both human
leukocytes and mouse tissues (Coviello-McLaughlin and Prowse, 1997; Okuda et al.,
2002). However, male telomeres tend to shorten more rapidly than female up until
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menopause. A potential mechanism that has been proposed is related to the protective
function of estrogen (Moller et al., 2009).
Telomere length dynamics with aging of hematopoietic stem cells (HSCs) is considered
to be one of the most reflective cell models of biologic aging. In fact, the most prominent
phenotypic consequence of defects in telomere length maintenance is bone marrow
failure as is seen in dyskerotosis congenital, Werner syndrome, and aplastic anemia.
Similarly in telomerase knockout mice, once telomeres are sufficiently short in late
generation mice, function of the hematopoietic system is compromised (Blasco, 2005b;
Herrera et al., 1999). Although telomerase is active in HSCs, telomeres shorten in culture
on average 1-2 kb per month (Engelhardt et al., 1997) as well as in vivo (Lee et al., 2003;
Vaziri et al., 1994). Seeing as telomere shortening outweighs telomerase activity, HSC
resources become exhausted with aging.
On the other hand, telomere lengthening with age is also observed. Telomere length in
spermatozoa is positively correlated with age such that offspring born with older fathers
tend to have longer telomeres at birth. A suggested mechanism of telomere lengthening
in germ cells is epigenetic modification and resistance to oxidative stress; however, it is
not yet fully understood (Kimura et al., 2008).
Longitudinal studies were necessary in order to understand the true impact of telomere
length with age. Using qPCR, two studies found a negative correlation of telomere
length with age over a 5 and 10 year period in 500 and 959 individuals, respectively.
However, in almost one third of individuals, no correlation with age has been found
(Aviv et al., 2009; Nordfjall et al., 2009).

Furthermore, significant decline of leukocyte

telomeres seen early in life was confirmed in a study with baboons, whose telomeres
were measured longitudinally over the first few years of life (Baerlocher et al., 2007).
More recently, a study with birds demonstrated that telomere length at birth is correlated
with life expectancy (Heidinger et al., 2012). Similarly, a genetic variant of the RNA
component of telomerase (TERC) is also linked to leukocyte telomere length and
longevity (Soerensen et al., 2012). Therefore, longitudinal studies are important to
elucidate clear relationships with age and other confounding factors.
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1.8.2

Telomere length and chronic illness

Age represents one of the greatest risk factors for chronic illness. Telomere length can
be considered a function of replicative history (age) and environmental stress, two
important parameters in the development of chronic illness (Oeseburg et al., 2010). A
clear link between telomere length and mortality in humans has been established
(Cawthon et al., 2003), but how telomere length correlates lifespan is still under debate.
Nonetheless, many studies provide evidence that telomere length is associated with agerelated illnesses, especially cardiovascular disease and cancer (Oeseburg et al., 2010).

1.8.2.1

Cardiovascular disease

Cardiovascular disease (CVD) is one of the main contributors to morbidity and mortality
in the aging population. Telomere length is a proposed biomarker of individuals at risk
for developing CVD. Several studies over the past decade have demonstrated the
relationship between short leukocyte telomere length and CVD (Table 1.3).
Table 1.3 - Short leukocyte telomere length and associated cardiovascular disorders
Cardiovascular disorder

Participants

Reference

Hypertension

96 cases; 98 controls

(Bhupatiraju et al., 2012)

327 men from FHS

(Demissie et al., 2006)

Left ventricular dysfunction

89 subjects (85 years old)

(Collerton et al., 2007)

Atherosclerosis

10 cases; 20 controls

(Samani et al., 2001)

164 hypertensive men

(Benetos et al., 2004)

1062 individuals from FHS

(O'Donnell et al., 2008)

203 cases; 180 controls

(Brouilette et al., 2003)

484 cases; 1058 controls

(Brouilette et al., 2007)

337 cases; 337 controls

(Zee et al., 2009)

Abdominal Aortic Aneurysms

190 cases; 183 controls

(Atturu et al., 2010)

Congestive heart failure

620 cases; 182 controls

(van der Harst et al., 2007)

Aortic dissection

72 cases; 72 controls

(Yan et al., 2011)

Cardiovascular mortality

143 subjects (>60 years old)

(Cawthon et al., 2003)

780 CAD subjects

(Farzaneh-Far et al., 2008)

Myocardial infarction
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FHS – Framingham Heart Study; CAD – coronary artery disease
Two major risk factors to CVD, diabetes and hypertension, have both been linked to short
telomeres. One of the key studies linking short telomeres to insulin resistance and
hypertension was the Framingham Heart Study (Demissie et al., 2006), later confirmed in
a Chinese (Yang et al., 2009) and Indian population (Bhupatiraju et al., 2012).
Hypertensive individuals with short telomeres are more susceptible to develop
atherosclerosis (Yang et al., 2009), and display increased risk of cardiovascular mortality,
stroke or angina pectoris (Fyhrquist et al., 2011). Even mild activation of the renninangiotensin system has been linked to shorter leukocyte telomeres (Demissie et al., 2006;
Vasan et al., 2008). Endothelial dysfunction, marked by cholesterol burden,
inflammatory markers, and increased oxidative stress, is considered an early marker of
atherogenesis (Asselbergs et al., 2005; van der Harst et al., 2006). Consistent with this,
senescent endothelial cells and short telomeres have been seen in atherosclerotic plaques
(Minamino et al., 2002; Ogami et al., 2004). The West of Scotland Primary Prevention
Study (WOSCOPS) determined that patients were more susceptible to develop coronary
heart disease if they were in the middle or lower tertile for telomere length. Patients with
shorter telomeres also benefited more from treatment with statins (Brouilette et al., 2007).
Furthermore, offspring of patients with coronary artery disease (CAD) have shorter
telomeres than those with healthy parents (Brouilette et al., 2008), and may explain part
of CAD heritability (Samani et al., 2007).
Several studies have linked short telomere length to glucose intolerance, insulin
resistance and type 2 diabetes (Adaikalakoteswari et al., 2005; Adaikalakoteswari et al.,
2007; Sampson et al., 2006). Even subclinical levels of insulin resistance were linked to
shortened telomeres in participants of the Framingham Heart Study (Demissie et al.,
2006). Patients with type 2 diabetes show signs of accelerated aging (accelerated
telomere attrition, increased oxidative damage, and decreased mitochondrial DNA)
compared to control subjects (Monickaraj et al., 2012).
Other cardiovascular risk factors are also associated with short telomeres. Arterial
calcification is also associated with short telomeres (Mainous et al., 2010). A study with
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Chinese stroke patients revealed that short telomere length is associated with ischemic
stroke and post-stroke death (Ding et al., 2012). Telomere length was determined in a
large prospective study of 19838 Danish participants followed for up to 19 years for
incident myocardial infarction, ischemic heart disease, and death. Short telomere length
was modestly correlated with increased risk of each outcome in the population (Weischer
et al., 2012).
Although an etiologic role for telomere length in CVD has yet to be established, a recent
study of 3271 Caucasians in the Cardiovascular Health Study aged ≥65 years old
revealed SNPs in OBFC1 (a gene linked to leukocyte telomere length) were associated
with CVD mortality in women (Burnett-Hartman et al., 2012a).

1.8.2.2

Cancer

A major factor influencing life expectancy is cancer, especially in long-lived species.
Short leukocyte telomere length is a risk for the development of many types of cancer,
including head and neck, breast, bladder, prostate, lung, kidney, ovarian (Blackburn,
2011; Martinez-Delgado et al., 2012; Wu et al., 2003).
As stated in section 1.4, dysfunction of the p53 pathway causes cells to continue to divide
until a state of crisis is reached. A series of breakage fusion bridge cycles between
chromosomes with dysfunctional telomeres causes genomic rearrangements that can
induce upregulation of oncogenes and promote tumorigenesis (Deng et al., 2008; Hackett
and Greider, 2002; Rudolph et al., 2001).

Mice with enhanced p53 responses show

increased resistance to cancer, however, have shorter lifespan and display age-related
phenotypes sooner (Donehower, 2002; Matheu et al., 2007). In contrast, Li-Fraumeni
syndrome (LFS) is characterized by a germline mutation in TP53, predisposing LFS
patients to cancer. With each consecutive generation there is earlier onset of cancer
caused by progressive telomere shortening in the germ cells. Therefore, telomere length
has been used as a biological marker to monitor LFS patients (Tabori et al., 2007).
Tumor cells also utilize one of two mechanisms to maintain their telomeres, providing
them with a means to overcome the end-replication problem. As stated earlier, 80-90% of
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all cancer cells express telomerase, and the remaining use the ALT pathway (Shay and
Bacchetti, 1997) or a combination of both (Venturini et al., 2012). Similar to enhancing
p53, suppression of telomerase can reduce risk of cancer, but it also induces age-related
phenotypes. However, reactivation of telomerase after 4 weeks reverses the degenerative
phenotypes seen in telomerase-deficient mice (Bernardes de Jesus and Blasco, 2011;
Jaskelioff et al., 2011). Proliferative capacity of post-senescent cells can also be
extended by ectopic expression of human TERT (Counter et al., 1998). However,
continued expression of hTERT in culture promotes genomic instability, perhaps due to
accumulation of replication errors from an extended lifespan in culture (Roth et al., 2005;
Schreurs et al., 2005).
The link between cancer and lifespan is a fine balance between protection against
tumorigenesis and degeneration due to age. By combining the protective effects of
enhancing p53 activity and increasing telomerase expression, the lifespan of mice can be
extended and risk of tumorigenesis reduced (Donate and Blasco, 2011; Tomas-Loba et
al., 2008).

1.8.3

Telomere length (TL) variation in the population

Telomere lengths are highly variable between and within individuals. Within an
individual, telomeres vary in length between tissues, cells, and chromosomes (Lansdorp
et al., 1996; Oeseburg et al., 2010; Zijlmans et al., 1997). However, variability between
individuals is greater than that within each individual, which makes cross-sectional
studies noisy, requiring large cohorts (Aviv and Levy, 2011; Kimura et al., 2010a;
Takubo et al., 2002). At birth, telomeres vary in the population by 4-6 kb in blood
leukocytes (Akkad et al., 2006; Frenck et al., 1998; Okuda et al., 2002), which is
maintained throughout the human lifespan (Alter et al., 2007; Rufer et al., 1999).
Telomere length variation in the population is a result of inherited differences, and
differential rates of telomere shortening between individuals (Aviv, 2012; Chen et al.,
2011). Both genetic and environmental or lifestyle factors contribute to differences in the
rate of telomere shortening.
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1.8.3.1

Genetic factors that influence telomere length

Genetic factors include inherited differences in birth telomere length and differences (i.e.
polymorphisms, mutations) in genes involved in telomere stability and maintenance, such
as shelterin and telomerase.

1.8.3.1.1

Inheritance of telomeres

Much of the variation in telomere lengths seen between individuals at birth could be the
result of inherent heterogeneity between germ cells. A twin-based study revealed that
telomere length is partly genetically determined. In this study, monozygotic twins had
telomeres similar in length, in contrast to heterozygotic twins (Slagboom et al., 1994).
Several studies have estimated that the contribution of heredity to telomere length in
humans is between 36 and 80% (Andrew et al., 2006; Jeanclos et al., 2000; Njajou et al.,
2007; Slagboom et al., 1994; Vasa-Nicotera et al., 2005). The precise mechanism of
heritability is still unclear, with some studies suggesting maternal mode of inheritance
(Nawrot et al., 2004) and others paternal (Njajou et al., 2007; Nordfjall et al., 2005;
Nordfjall et al., 2010). One study suggests telomere length may be inherited as an Xlinked trait, based on the fact that telomere length was correlated between parents of both
sexes and offspring except between father and sons (Nawrot et al., 2004). In line with
this, telomere length from umbilical cord blood of newborn babies correlated with
maternal blood telomere length (Akkad et al., 2006). However, a recent large-scale
study confirms that paternal influence on offspring telomere length is significantly
greater than maternal contribution (Nordfjall et al., 2010). In fact, several studies
confirm that age of father is positively correlated with offspring telomere length at birth
(De Meyer et al., 2007; Njajou et al., 2007; Unryn et al., 2005). In the human male
germline, telomere lengths are highly heterogeneous (8.8 to 16 kb) between cells, even
with telomerase expression (Baird et al., 2006). Similarly, offspring of inbred mice
showed variable telomere lengths in the Y chromosome (Zijlmans et al., 1997).
Many studies are using genome-wide sequencing approaches to determine genetic loci
that are associated with telomere length. These studies have revealed that genetic
variants of telomerase RNA component (TERC) (Codd et al., 2010; Levy et al., 2010;
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Njajou et al., 2010; Shen et al., 2011; Soerensen et al., 2012) and catalytic subunit
(TERT) (Atzmon et al., 2010) are associated with leukocyte telomere length and
longevity. One study in families with exceptional longevity of Ashkenazi centenarians
revealed an association between telomere length, longevity and a genetic variant in
hTERT (Atzmon et al., 2010). Heterozygous mutation in either hTERC or hTERT genes
lead to rare disorders of aplastic anemia and dyskerotosis congenital, characterized by
bone marrow failure (Garcia et al., 2007). Furthermore, a recently discovered genetic
variant in OBCF1 is associated with inter-individual variation in leukocyte telomere
length (Levy et al., 2010) and a potential link to cardiovascular disease (Burnett-Hartman
et al., 2012b). OBCF1 plays a role in telomere length regulation and can interact with
shelterin protein TPP1 (Wan et al., 2009).
Insights in inheritance patterns in telomere lengths also come from studies using inbred
mice over several generations. One study revealed that heterozygous knockouts in the
catalytic subunit of telomerase (TERT+/-) caused subsequent shortening of telomeres
over generations (Chiang et al., 2010). However, when telomerase activity was restored,
telomeres stabilize at a new set-point over subsequent generations. The authors proposed
that telomere length set-points can be reset based on inherited telomere lengths. Mice
with short telomeres were then backcrossed to the original mice with long telomeres and
found that the offspring had an average length intermediate to the parental mice,
suggesting telomere lengths do not represent a simple heritable trait. Genotype alone
does not determine telomere set-point, but historic events (telomerase haploinsufficiency)
can influence inherited lengths (Chiang et al., 2010). Between-species crosses of Mus
musculus (long telomeres) and Mus spretus (short telomeres) showed a select lengthening
of the short telomeres inherited from Mus spretus (Zhu et al., 1998). This lengthening
was mapped to a specific gene encoding the Rec helicase (Rtel) (Ding et al., 2004). The
mechanism of action is not fully understood, however, genetic differences of telomereassociated proteins may account for elongation of telomeres between species. In
addition, telomere elongation may only occur when recognized as critically short, which
may be different for each species of mice (Chiang et al., 2010).
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1.8.3.1.2

Progeroid syndromes

Much of what we know about telomeres with aging in vivo comes from the study of
progeroid (premature aging) syndromes. These include Werner and Bloom syndrome
(Rossi et al., 2010) and dyskeratosis congenita (Armanios, 2009; Walne and Dokal,
2009). These disorders are characterized by mutations in genes encoding proteins
involved in telomere length stability and regulation. Accelerated telomere shortening in
these disorders clinically manifests as aplastic anemia in bone marrow and fibrosis of the
lung and liver, leading to premature mortality (Armanios, 2009). Mouse models have
been used to study the effects of progeroid proteins on telomere length with aging by
functional knockout of telomerase (TERT-/- or TERC-/-), Werner (WRN-/-), and
dyskerin (DKC1) (Blasco, 2005a; Chang, 2005; Chang et al., 2004; Walne and Dokal,
2009). Mutations in shelterin components, such as TIN2, can also cause dyskeratosis
congenita (Walne and Dokal, 2009).
One study generated wild-type mice with short telomeres and found that these mice
displayed accelerated age-related pathologies similar to patients with dyskeratosis
congenita (Armanios et al., 2009). These mice had defects in the hematopoietic and
immune system, and persisted several generations of interbreeding. These findings
suggest that inheritance of short telomeres even in the presence of wild-type telomerase is
sufficient to cause degenerative defects with age (Armanios et al., 2009).
Accelerated aging has also been observed in mice with null mutations in the catalytic
subunit of DNA-dependent protein kinase (DNA-PKcs) (Espejel et al., 2004). In
complex with the heterodimer Ku86/Ku70, DNA-PK plays a role in DNA repair by nonhomologous end joining (Khanna and Jackson, 2001). However, these proteins also
participate in telomere capping and are thought to assist in recruitment of telomerase
(Espejel et al., 2002). Absence of DNA-PKcs accelerates telomere shortening and leads
to earlier onset of age-related pathologies (Espejel et al., 2004).
Furthermore mice with knockouts of shelterin components, such as TRF1, TPP1 and
Rap1, have helped establish in vivo roles in telomere maintenance and genomic stability
(Donate and Blasco, 2011). For example, TRF1 knockouts lead to embryonic lethality at
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the blastocyst stage, but Cre recombinase-mediated conditional knockout of epithelial
cells revealed rapid induction of p53 mediated senescence, damaged foci at telomeres,
chromosomal fusion events, and genomic instability. Knocking out p53 rescued some of
the defects, but these mice still displayed abnormalities of human conditions linked to
telomere maintenance deficiency such as nail atrophy and oral leukoplakia (Donate and
Blasco, 2011).

1.8.3.2

Lifestyle factors that influence telomere length

Telomere shortening rates can be modified by several lifestyle factors that include mental
stress levels, cigarette smoking and dietary intake. Baseline telomere shortening due to
the end-replication problem will always exist, but efforts to live a healthy and balanced
lifestyle can reduce any additional loss of telomeres (Shammas, 2011). Even poor sleep
quality has been associated with shorter telomere lengths in leukocytes among midlife
women, independent of perceived psychological stress (Prather et al., 2011).

1.8.3.2.1

Mental stress

The amount of stress experienced is a key factor in variations in telomere shortening
among the adult population. Female house mice (Mus musculus) that experienced
reproductive stress displayed shorter telomeres compared to controls. In male mice,
crowding stress also resulted in shorter telomeres (Kotrschal et al., 2007). In humans,
psychological stress has been linked to short telomeres (Lin et al., 2012). Leukocyte
telomere lengths were analyzed in mother’s caring for their chronically sick child and
revealed that duration of care was associated with higher levels of oxidative stress, lower
levels of telomerase and shorter telomeres. In fact, the level of stress perceived by the
caregiver was proportional to their telomere lengths (Epel et al., 2004). Caregivers
experience exaggerated anticipatory stress appraisals, which may have a negative impact
on telomere length and cellular age (O'Donovan et al., 2012). Another study confirmed
that high levels of perceived stress and chronic pain among adults is associated with short
telomeres (Sibille et al., 2012).
Telomere shortening due to stress does not occur only in adults but also in children.
More recently, Blackburn’s lab revealed that socioeconomic status of parents is positively
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correlated with child leukocyte telomere length. Children with parents that never
attended college had telomeres 1178 bp (~6 years of additional aging) shorter than
children with at least one college-educated parent (Needham et al., 2012). Moreover,
exposure to violence between ages 5 and 10 resulted in significantly reduced leukocyte
telomeres, providing evidence for early childhood stress and telomere maintenance
(Shalev et al., 2012). However, activities that reduce stress levels, such as meditation
(Epel et al., 2009; Jacobs et al., 2011) and exercise (Puterman et al., 2010), can improve
telomere length and reduce rates of telomere shortening. In fact, a mindfulness
intervention study revealed that metabolic and psychological stress in part may regulate
telomerase activity (Daubenmier et al., 2011).

1.8.3.2.2

Smoking, obesity and dietary intake

There are several studies that link cigarette smoking to short leukocyte telomeres
(Babizhayev and Yegorov, 2011; McGrath et al., 2007; Mirabello et al., 2009; Morla et
al., 2006; Nawrot et al., 2010; Valdes et al., 2005). In a study of women who smoke, a
pack of cigarettes a day causes an additional telomere loss of 5 bp/year, equivalent to 7.4
years of aging after 40 years of smoking (Valdes et al., 2005). Studies have also shown a
dose-effect relationship between tobacco exposure and telomere length (McGrath et al.,
2007; Morla et al., 2006). Accelerated telomere shortening in smokers is linked to
increased oxidative stress and DNA damage (Babizhayev and Yegorov, 2011). In fact,
an in vitro model of early mice embryos revealed that exposure to cigarette smoke
condensate or cadmium caused increased oxidative stress and telomere shortening and
associated with chromosomal instability and apoptosis. However, treatment with the
antioxidant N-acetyl-l-cysteine (NAC) was able to greatly reduce oxidative stress and
toxic effects of cigarette smoke (Huang et al., 2010).
Similar to smoking, obesity also causes an increase in oxidative stress and inflammation
(Codoner-Franch et al., 2011). Short leukocyte telomere length in type-2 diabetic men
was shown to correlate with triglyceride and total cholesterol levels, suggesting a link
between BMI and telomeres in aging (Harte et al., 2012). A diabetes intervention study
on obese individuals with glucose intolerance revealed that by promoting a healthy
lifestyle leukocyte telomere length can improve over time (Hovatta et al., 2012). Even a
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moderate amount of physical activity is associated with longer leukocyte telomere
lengths (Du et al., 2012).
Proper dietary intake can also improve telomere length. For instance, vitamin D intake
was linked to increased telomerase activity in leukocytes of overweight individuals (Zhu
et al., 2011) and improved telomere length in hemodialysis patients treated with vitamin
D compared to those not treated (Borras et al., 2012). Since oxidative stress accelerates
telomere shortening, intake of antioxidants, such as berries, could reduce rates of
telomere attrition. A study with mice showed that treatment with the antioxidant NAC
effectively postponed aging of oocytes and displayed longer telomeres and higher
telomerase expression than controls (Liu et al., 2012). As with mental stress, exercise
can also modify telomere length attrition by improving overall health and by reducing
BMI and oxidative stress levels (Shammas, 2011). In fact, exercise altered telomere
maintenance and slowed age-related decrease in telomere length of the lung and heart of
mice. However, exercise caused telomere shortening in skeletal muscle of mice compared
to sedentary mice, suggesting its protective effects are tissue dependent (Ludlow et al.,
2012).

1.8.4

Goals of this study

In humans, it is well established that telomeres shorten with age in blood leukocytes and
that short leukocyte telomere lengths are associated with cardiovascular disease (CVD)
(Oeseburg et al., 2010). In wild-derived Mus spretus mice, telomeres also shorten in
spleen, a leukocyte-rich tissue (Coviello-McLaughlin and Prowse, 1997). Mus spretus
mice have telomeres in range with that of humans, whereas commonly used inbred strains
have telomeres significantly longer (Hemann and Greider, 2000). Therefore, few studies
have used inbred mice to study telomere dynamics, leaving them poorly understood. It is
important to understand telomere dynamics in strains that are commonly used for a widerange of genetic studies (e.g. C57BL/6). No study to date has looked at telomere length
dynamics with age in different strains of inbred mice. Furthermore, there is little
information on tissue-specific differences in telomere length with age of inbred mice.
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As mentioned in section 1.8.3, large inter-individual variations in leukocyte telomere
length and its rate of change make use of cross-sectional studies difficult, which can only
detect telomere length changes of an entire population. By knowing birth telomere
length of an individual, telomere loss and rate of change could be determined. A
previously defined quasi-longitudinal model in dogs uses a post-mitotic tissue (skeletal
muscle) as an estimate of birth telomere length to reference against leukocyte telomere
length in adults (Benetos et al., 2011). However, many cell types are considered postmitotic, but a tissue would need to be predominantly composed of these long-living cells
in order to be a good estimate of birth telomere length. No study to date has defined a
tissue to estimate birth telomere length on a genetically constant model. Moreover, no
study has determined if genetic diversity is the cause of telomere length heterogeneity in
the population.
Goals:
1) To determine if there are strain-specific differences in telomere lengths of inbred
mouse strains.
2) To determine if there is an adult tissue that can serve as a surrogate for
ascertaining birth telomere length.
3) To determine if genetic heterogeneity translates to telomere length heterogeneity
in a mouse population.
4) To determine if elucidating age-related associations of telomere length in a
genetically heterogeneous mouse population can be optimized by referencing to a
tissue with stable telomere length.
5) To determine if the extracellular matrix can influence telomere length.

1.9
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Chapter 2 - Aortic media defines telomere length
dynamics in mice
2.1

Abstract

Leukocyte telomere length (TL) shortens with age and is associated with age-related
pathologies. However, inherited and acquired variations in telomere length in individuals
complicate the clinical interpretation of TL as a biomarker of aging and age-related
pathologies. Therefore, it may be valuable to identify a post-mitotic adult tissue as a
surrogate marker of TL at birth. Many tissues are considered post-mitotic however in
order for an adult tissue to have telomeres of similar length to that at birth two criteria
need to be met: 1) the tissue be composed of non-replicating cells and 2) the tissue be
relatively homogeneous in cell type composition. The purpose of this study was 1) to
establish an adult tissue that serves as a marker for birth TL; 2) determine if use of this
tissue corrects for genetic diversity; 3) characterize a mouse system that displays humanlike telomere dynamics; 4) determine if a pathological state of impaired turnover of
collage type I is associated with telomere shortening.
I compared TL in the first year of life in common inbred strains (C57BL/6 (N=63), 129sv
(N=19), and Balb/c (N=18) to Diversity Outbred (DO) mice (N=51), a strain bred to
maintain allelic heterogeneity. Mean TL was determined using quantitative PCR by
measuring telomere-to-single copy gene (T/S) ratio. I found that C57BL/6 telomeres are
shortest among the inbred strains tested (P<0.0001), with age-related shortening of
telomeres in spleen (P<0.0001), bone marrow (P=0.0015), skeletal muscle (P=0.025), and
brain (p<0.0001). In contrast, aortic media and heart had stable TL with age.
Furthermore, adult aortic media TL was not different from aortic TL at birth. I also
identified spatial heterogeneity in telomere length across the aortic wall of C57BL/6 mice
(TL of intima<adventitia<media, P<0.001), which increased with age.

DO mice were

found to have long telomeres characteristic of inbred strains but more variable in length.
Intra-mouse TL synchrony between spleen and aortic media in DO mice (R2=0.51,
P<0.0001) provided a means to correct for genetic diversity, revealing age-related
telomere shortening of spleen referenced to aortic media in each individual mouse
(P<0.0055). The relationship with age of the intima also improved by referencing to
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aortic media TL (R2=0.52; P=0.0003 to R2=0.61; P<0.0001). Lastly, I determined in a
collagenase-resistant collagen mutant (Col1a1r/r) mouse that telomere length of heart and
skeletal muscle is significantly lower than wild-type controls (P=0.006 and P=0.008,
respectively).
In conclusion: 1) human-like telomere attrition with age can be detected in some inbred
mouse strains; 2) TL in aortic media may serve as an internal reference for determining
rate of leukocyte TL shortening; and 3) impaired collagen turnover accelerated telomere
shortening in collagen-rich tissues.

2.2

Introduction

In humans, short leukocyte telomere length (LTL) has been shown to correlate with age
and age-related illnesses, in particular cardiovascular disease (CVD) (Balasubramanyam
et al., 2007; Farzaneh-Far et al., 2010; Fitzpatrick et al., 2007; Oeseburg et al., 2010).
Insulin resistance and hypertension are also associated with short LTLs (Demissie et al.,
2006), as well as homocysteine levels (Richards et al., 2008), all of which are risk factors
for CVD. Furthermore, short LTL is associated with type-2 diabetes mellitus (Salpea et
al., 2010; Sampson et al., 2006; Zee et al., 2010) and many forms of cancer (Hou et al.,
2009; Jang et al., 2008; McGrath et al., 2007; Risques et al., 2007; Willeit et al., 2010).
Several genetic variants in telomerase RNA (TERC) have been linked to increased risk of
both cancer (Hills and Lansdorp, 2009; Jones et al., 2012; Sheng et al., 2012; Varadi et
al., 2009) and CVD (Burnett-Hartman et al., 2012; Zee et al., 2011), suggesting a genetic
link between LTL and chronic illness. Recently, a longitudinal study revealed early life
LTL as a predictor of lifespan in birds (Heidinger et al., 2012), implicating birth telomere
length as a determinant of biological fitness with potential for risk assessment of chronic
illnesses.
LTL in the adult can be expected to be a product of both birth telomere length and rate of
telomere shortening and there are large variations in LTL in the population (Aviv, 2011).
In newborns, LTL varies 4-6 kb between individuals and this variability sustains
throughout human lifespan (Frenck et al., 1998; Rufer et al., 1999). Furthermore,
telomere length attrition is variable among individuals (Chen et al., 2011). Since most
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human studies are cross-sectional, only a snapshot of LTL at a single time is known
(Aviv, 2011). Therefore, it would be valuable to know birth telomere length of an
individual, in order to determine the rate of telomere shortening for that individual.
Recently, work has been done in canine and macaques to use certain tissues as an internal
reference or marker of birth telomere length, such as skeletal muscle and adipose tissue,
chosen because of their post-mitotic nature (Benetos et al., 2011; Gardner et al., 2007).
However, to date no study has assessed in detail differences in telomere lengths in a
variety of tissue types on a genetically constant model to determine which tissue, if any,
best represents birth telomere length.
Although many cell types in vivo are considered post-mitotic, the ideal marker of birth
telomere length would likely be tissues with cell types that are long-lived and seldom
renewed. Myocytes of the cardiovascular system such as cardiomyocytes and smooth
muscle cells (SMC) as well as the aforementioned skeletal muscle are candidates as a
marker for birth telomere length. Smooth muscle and skeletal muscle of healthy adults
show little cell turnover post-natally with an average age of 15.9 and 15.1 years,
respectively (Spalding et al., 2005). Cardiomyocytes have an average age of 6 years
younger than the individual (Bergmann et al., 2009), although only represent 20% of the
human myocardium (Rubart and Field, 2006). Although neurons may be the longest
living post-mitotic cells, particularly from the cerebellum with an average age of 2 years
younger than the individual (Spalding et al., 2005), they are not practical as a tissue to
biopsy for telomere measurements.
All tissues are composed of a variety of different cell types at different proportions.
Unless cell sorting is used, which is time consuming and costly, for a tissue to be a
surrogate for birth tissue with respect to telomere length, it would have to be almost
entirely composed of post-mitotic cells. Therefore, two criteria need to be met for a
tissue to serve as a surrogate for birth telomere length: 1) composed of a long-lived cell
type and 2) homogeneous population of said cells. The aorta may be a good candidate
since the media layer can be isolated mechanically and represents a relatively
homogeneous population of vascular SMC.

66

In this study, I used inbred mice to assess telomere dynamics. Inbred mice provide a
powerful tool to control genetics, isolate a trait of interest and selectively modify gene
function. Moreover, understanding telomere dynamics of inbred mice may allow us to
capitalize on the plethora of disease models readily available, short lifespan and short
replication time. Finally, it’s important to understand telomere dynamics of commonly
used inbred strains in order to make inter-study comparisons regarding disease and
genetics.
Inbred mice have been the most common animal models in lab for decades, but there is
very limited knowledge on their telomere length dynamics with age. Murine telomere
dynamics were originally characterized in wild-derived mice, Mus spretus, because their
telomeres are closer in length to those of humans (10-15 kb) than established inbred
strains (Prowse and Greider, 1995). Mus musculus strains, such as C57BL/6, Balb/c and
129, have telomeres on average between 30-80kb, producing large smears on agarose
gels that are difficult to resolve and detect differences (Kipling and Cooke, 1990).
Moreover, unlike primary human fibroblasts, primary mouse embryonic fibroblasts cells
are not prone to telomere shortening as dividing in culture, partially attributed to the
activation of telomerase and spontaneous immortalization (Sachsinger et al., 2001).
Telomeres of inbred mice have thus been scrutinized as representing a poor model to
study telomeres. However, since the development of quantitative PCR (qPCR)-based
telomere length measurements, average telomere length can be easily and accurately
determined with minimal starting material compared to the gold standard southern
blotting technique (Aviv et al., 2011; Cawthon, 2002).
I used qPCR to evaluate the relationship of mouse strain and tissue on age-dependent
telomere length dynamics in mice. Using C57BL/6 mice and a unique strain of Diversity
Outbred mice that has human-like genetic diversity, I established telomere length in
aortic media as a surrogate for birth telomere length, and internal reference for
determining age-dependent attrition in spleen cells (leukocytes).
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2.3
2.3.1

Materials and methods
Animals and tissue

All mice used in this study were male except for C57BL/6 neonates, which were a mix of
male (N=9) and female (N=2). Inbred mice (C57BL/6 (N=60), 129sv (N=10), Balb/c
(N=17), and Diversity Outbred (N=49)) were purchased from Jackson Laboratory (Bar
Harbor, ME). C57BL/6 mice at 15.3 months (N=3) of age were purchased from Charles
River Laboratories (Sherbrooke, ON). Collagenase-resistant collagen mutant (Col1a1r/r)
mice (N=5) and wild-type controls 129P1/re (N=8) were bred and maintained at Western
University (London, ON). Wild-type 129 mice used throughout the study include both
the 129sv and 129P1/re, so are referred to as simply 129 in some contexts. Note that N
number may vary between groups in experiments because samples were extracted from
banked tissues.
Mice were anaesthetized and blood was collected in 0.5M EDTA from the left ventricle.
Mice were then perfused with 1xPBS, and tissue (heart, liver, spleen, skin, aorta, skeletal
muscle, and brain) was collected and flash frozen in liquid nitrogen and stored at -80oC
until further use. DNA from blood and bone marrow was immediately isolated following
tissue extraction.

2.3.2

Tissue preparation

Prior to DNA isolation, all tissues were first thawed in 1xPBS. For the heart, the left
ventricle was sampled, and skeletal muscle was sampled from the adductor muscle.
Whole blood was processed using a red blood cell lysis buffer (Qiagen Inc., Mississauga,
ON) to ensure purity of its DNA. The aorta of a subset of C57BL/6 mice (N=23) was
dissected into its three layers (intima, media, and adventitia) prior to DNA isolation.
After the adventitia was peeled off with forceps, the aorta was cut in half longitudinally
in a small pool of 1xPBS, and the intima was careful scraped off using L-shape forceps.
For mice at 4 and 10 months, the endothelium was pooled from two or three mice, and
for mice at 14 months the endothelium was from individual aortas. The medial layer of a
subset of those aortas (N=12) was further segmented into four partitions: 1) lower
abdominal located infra-renal; 2) upper abdominal located supra-renal and below
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diaphragm; 3) lower thoracic, the lower half between the diaphragm and mid aortic arch;
and 4) upper thoracic, the upper half of the former.

2.3.3

DNA isolation and quantitation

DNA from all tissue samples was isolated using the DNA mini or micro kit (Qiagen Inc.,
Mississauga, ON) depending on sample size/volume; for tissue less than 5 mg and blood
less than 50 µL, the micro kit was used. SPRET/Ei DNA was acquired from Jackson
laboratory (Bar Harbor, ME) from spleen of 1 month old male mice.
DNA quantification was done using the picogreen kit (Invitrogen, Burlington, ON).
Briefly, lambda DNA provided with the kit was serially diluted by 2-fold in 1xTE from a
concentration of 2000 ng/µL to yield an 8-point standard curve. Standards and samples
were loaded onto black Nunc-Immuno 96-well plates (Sigma-Aldrich, Oakville, ON) at a
100x dilution in working picogreen solution (200-fold dilution of stock). A non template
control was included as a blank. The excitation and emission wavelengths were set to
485 nm and 530 nm, respectively, and fluorescence was measured using a SpectraMax
M5 fluorescent plate reader (Molecular Devices Corp., Sunnyvale, CA). Data were
exported to Microsoft excel to calculate the initial concentration of each sample based on
the equation of the standard curve. Concentrations above 30 ng/µL were diluted in 1xTE
buffer to an intermediate working concentration of 10 ng/µL and quantified a second time
with picogreen. All samples were diluted to a final working concentration of 4ng/uL in
1xTE buffer and stored at -80oC until further use.

2.3.4

Telomere length measurement by qPCR

An average telomere length was determined using a qPCR approach as previously
described by Cawthon (Cawthon, 2002) and optimized for mice by Callicott (Callicott
and Womack, 2006). Average telomere length is calculated based on a standard curve of
a reference sample by measuring the quantity of telomeric repeats to single-copy gene
(T/S ratio) as shown in appendix B.
The sequence of the telomere-specific forward (tel1b) and reverse (tel2b) primers
(Sigma-Aldrich, Oakville, ON) was 5’ CGG TTT GTT TGG GTT TGG GTT TGG GTT
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TGG GTT TGG GTT 3’ and 5’ GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC
CCT TAC CCT 3’, respectively. The single-copy gene, acidic ribosomal phosphoprotein
PO (36B4), was used to normalize for cell count. The sequence of the 36B4-specific
forward (36B4u) and reverse (36B4d) primers (Sigma-Aldrich, Oakville, ON) was 5’
ACT GGT CTA GGA CCC GAG AAG 3’ and 5′TCA ATG GTG CCT CTG GAG ATT
3’, respectively.
Each reaction sample contained 5 µL of RT2 SYBR green master mix with ROX
(SAbiosciences, Mississauga, ON), 300 nM of both tel1b and tel2b primers or 300 nM of
36B4u and 500 nM of 36B4d primers, and topped off with nuclease-free water to yield a
total volume of 10 µL. To determine the optimal amount of DNA to use, an array of
DNA quantities (10 ng, 5 ng, 1 ng, and 300 pg) was tested on 5 samples of DNA from the
same spleen and the DNA quantity (5 ng) with consistent results and the lowest
coefficient of variation (CV) was chosen (Figure 2.1). A non-template control was
included on each plate as a negative control for non-specific amplification. Genomic
DNA from spleen of an individual mouse was used as reference DNA by serially diluting
25 ng by 1.68 fold in 1xTE buffer to yield a 7-point standard curve. Six to eight samples
acted as inter-plate controls and were included in each experiment to normalize for interexperimental variability as previously described (Aviv et al., 2011). The T/S ratio of
these inter-plate controls varied by 12.83±3.4% (CV±SD) based on the average of 7
qPCR experiments.
The assay was prepared in triplicate on two separate optically clear 384-well plates and
samples were matched well-to-well. The plate designated to measure telomeres had the
following thermal profile: 95°C hot start for 10 min, followed by 30 cycles of
denaturation at 95°C for 15 sec, and anneal-extension at 56°C for 1 min. The thermal
profile for 36B4 was: 95°C hot start for 10 min, followed by 35 cycles of denaturation at
95°C for 15 sec and anneal-extension at 60°C for 1 min. The experiment was carried out
using a 7900HT Real-time PCR machine (Applied Biosystems, Burlington, ON).
Following the PCR reaction, the threshold and baseline were manually adjusted as
necessary using SDS 2.4 software (Applied Biosystems, Burlington, ON) to optimize the
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standard curve to yield a slope between -3.1 and -3.6 and an R2 greater than 0.98. The
data were exported to Microsoft Excel and a T/S ratio and standard deviation was
calculated for each sample.

2.3.5

Statistical analysis

All data were analyzed using Graph Pad Prism version 5.0. Telomere lengths with age
(Figure 2.2B,C,D,2.3,2.7C,D,E,F,2.8A,B,C) and correlation of telomere lengths (Figure
2.7B) were analyzed using linear regression, and the equation of the best fit line, R 2, and
P value were reported on each corresponding graph. Telomere lengths of different strains
(Figure 2.2A) were compared using One-Way ANOVA and Tukey’s post-test. Telomere
lengths of neonatal and 1-6 month old C57BL/6 mice in both aorta and heart (Figure 2.4)
and wild-type versus mutant Col1a1r/r mice (Figure 2.9) were compared using two-tailed
student t-tests; aorta and heart at a given age were also compared with a paired student ttest. Aortic layers (Figure 2.5) at various time points were compared using Two-Way
ANOVA and Bonferroni post-test. The variance in telomere lengths of each strain were
compared using Bartlett’s test of equal variance (Figure 2.7A). Reliability of T/S ratio
measurements by qPCR using different DNA quantities (Figure 2.1) and telomere lengths
of different aortic regions (Figure 2.6) were compared using repeated measures One-Way
ANOVA followed by Tukey’s post-test.

Results

2.4
2.4.1

Optimization of qPCR telomere length measurement for
mice

To optimize the reliability of qPCR measurement of telomere length in mice, a
concentration analysis of different DNA quantities was performed. My goal was to
determine a range of DNA quantities that produce stable average telomere length
measurements (T/S ratios). A single spleen from a 1-month-old C57BL/6 male mouse
was divided into five pieces and DNA was isolated and quantified for all five samples
separately. Reactions were set up with varying amounts of DNA (300 pg, 1 ng, 5 ng, and
10 ng) loaded in triplicate on each 384-well plate for each sample in a single experiment
(Figure 2.1).
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Figure 2.1 - Reliability of T/S ratio measurements using different DNA quantities
T/S ratios were determined from a qPCR reaction using different quantities of DNA,
harvested from five tissue samples of a spleen from a 1-month-old male C57BL/6 mouse.
The data were plotted using whisker box plot to show the spread of data. Whisker box
plots graphically display the spread of data by grouping in its five-number summaries:
sample minimum, lower quartile, median, upper quartile and sample maximum. T/S ratio
is stable when between 1-10 ng of DNA was loaded in each reaction well. Five ng of
DNA was chosen to carry out all qPCR-based telomere measurements for this thesis.
*P<0.0001

72

This revealed that T/S ratios were consistent from 1 to 10 ng of DNA. However, 300 pg
produced T/S ratios that were significantly higher than the other concentrations. These
data suggest <1 ng of DNA for the qPCR reaction is too low for determining a reliable
T/S ratio.
The coefficient of variation for telomere measurements of each 300 pg, 1 ng, 5 ng, and 10
ng of DNA loaded were 19.52%, 12.66%, 9.73%, and 11.78%, respectively. Therefore, 5
ng was chosen to carry out qPCR telomere length measurements, as this represented a
balance between a small amount of DNA and reproducible T/S ratios.

2.4.2

Telomere length changes with age are strain specific

I next began to characterize telomere length dynamics with age in mice. First, I measured
and compared telomere lengths of spleen DNA from inbred (C57BL/6 (5.1±1.84
months), Balb/c (5.8±2.1 months) and 129 (6.3±2.5 months)) and wild-derived SPRET/Ei
mice (1 month). SPRET/Ei mice are known to have telomeres similar in length to human
telomeres, so were used as a reference for short telomeres. This assessment revealed that
SPRET/Ei telomeres were significantly shorter than telomeres of the three inbred strains
(P<0.0001) (Figure 2.2A). Furthermore, telomeres from the spleen of C57BL/6 mice
were significantly shorter than those of 129 mice (P<0.0001), which were shorter than
those of Balb/c mice (P<0.05). These findings indicate that inbred mice had long
telomeres and displayed strain-dependent differences in telomere length.
I next determined if telomere shortening with age could be detected in inbred strains of
mice and, if so, if genetic background influenced telomere length dynamics with age.
Spleen is a leukocyte-rich tissue, is highly proliferative, and has previously shown
telomere shortening with age in Mus spretus mice (Coviello-McLaughlin and Prowse,
1997). Therefore, I measured telomere lengths (1-16 months) in whole spleen of inbred
mice (129, Balb/c, C57BL/6). C57BL/6 mice displayed significant telomere shortening
with age (P<0.0001) (Figure 2.2B). In contrast, Balb/c displayed an increase in telomere
length with age (P=0.001) (Figure 2.2C), and 129 mice showed no age-related changes in
telomere lengths (Figure 2.2D). These findings indicate that murine telomere length
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Figure 2.2 - Inbred mouse strain differences in spleen telomere lengths
A) T/S ratios (+SD) were measured in whole spleen DNA of adult inbred mice: C57BL/6
(5.1±1.84 months; N=18), Balb/c (5.8±2.1 months; N=9), 129 (6.3±2.5 months; N=9),
and wild-derived mice (SPRET/Ei) (N=3) (For different letters P<0.001, except for b and
c P<0.05). Telomere length changes with age were also measured in the spleen of B)
C57BL/6 (1-16 months; N=49), C) Balb/c (1-12 months; N=18), and D) 129 (1-16
months; N=19). These mice include the subset measured in panel A. The equation of the
best fit line, R2, and P-value are reported on each graph.
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dynamics with age are strain-specific. As well, they show that C57BL/6 mice can serve
as an animal model that displays telomere shortening with age.

2.4.3

Age-related changes of telomere lengths in C57BL/6 mice
differ among tissues

To approximate birth telomere length, a tissue must have a stable telomere length with
age. However, little is known about the rate of telomere attrition in solid organs,
particularly in mice. Therefore, having identified detectable age-related shortening of
leukocytes in C57BL/6 mice, I used this strain to compare telomere dynamics among
different tissues.
I selected tissues rich in muscle, as these are generally considered post-mitotic tissues, as
well as brain and bone marrow. Telomeres in DNA harvested from bone marrow showed
significant telomere shortening over 1 to 16 months of age (P=0.0001) (Figure 2.3).
Interestingly, telomere attrition was also detectable over this time in skeletal muscle
(P=0.023) and also in brain (P<0.0001). In contrast, age-related declines in telomere
length were not detected in heart, aortic media and blood leukocytes.

2.4.4

Aortic media telomeres are stable in early life development

Telomeres in humans (Frenck et al., 1998), baboons (Baerlocher et al., 2007) and pigs
(Jiang et al., 2004) are shown to shorten within the first few months of birth, in part
because of rapid growth during that time. Given the relative stability of telomere length
in the heart and aortic media, I assessed for this drop in these tissues. Respective tissue
was harvested from neonates and compared with the average telomere length from 1-6
month-old C57BL/6 mice. In neonates and post-natally, the aortic media had telomeres
that were significantly longer than that of heart (neonates: 1.76±0.28 vs. 1.42±0.22,
P<0.0013; postnatal: 1.71±0.27 vs. 1.21±0.22, P=0.0002) (Figure 2.4). Interestingly,
there was no difference in aortic telomere length at birth with that of aortic media of older
mice (P=-0.63). However, heart telomeres at birth were significantly longer than that
from heart harvested from older mice (P=0.019). Thus, aortic media displays remarkable
length stability throughout neonatal growth and development and during adult aging.
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Figure 2.3 - Telomere length dynamics with age in different tissues of C57BL/6 mice
T/S ratios were measured in different tissues (bone marrow (N=40), brain (N=38), aortic
media (N=48), heart (N=63), skeletal muscle (N=62), and blood leukocytes (N=37))
harvested from C57BL/6 mice at different ages (1-16 months). The equation of the best
fit line, R2, and P-value are reported on each graph.
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Figure 2.4 - Telomere length changes in early life of C57BL/6 aorta and heart
T/S ratios were measured in aortic media and heart in neonatal (1 day old) C57BL/6 mice
(N=12) and compared to post-natal (1-6 months old) C57BL/6 mice (N=16). P-values are
reported on each graph.
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2.4.5

Telo-mapping identifies age-dependent, spatial telomere
length gradients in the aortic wall

The aorta is derived of 3 distinct layers and each comprised of different cell types. To
determine if variations in telomere length dynamics could be identified within these
layers, I isolated each layer individually. The intima was scrapped off the vessel, the
media and adventitia were dissected apart, and DNA was harvested from each layer
separately. At 4 months, there was no difference in telomere length among the intima,
media and adventitia (Figure 2.5). However, at 10 and 14 months, telomere length in the
endothelial layer had declined and was now significantly less than that of the aortic media
(P<0.001). Telomere length of the adventitial layer was also significantly less than the
aortic media, but greater than the intimal layer, at 10 and 14 months (P<0.01). Thus, an
age-dependent spatial gradient within the aortic wall evolved.

2.4.6

Telomere length along the length of aortic media reveals
shorter telomeres in the infra-renal aorta

Different regions of the aortic media are composed of smooth muscle cells of different
developmental origins (Majesky, 2007). Therefore, I assessed whether there were
differences in telomere length in the aortic media along the length of the aorta. For this,
the aorta of 4-14 month old mice was partitioned into four segments. Telomeres of the
infrarenal abdominal aorta were significantly shorter (P=0.0014) than the other three
levels of the aorta (Figure 2.6). However, no differences in telomere length between
upper thoracic, lower thoracic, and supra-renal abdominal aorta were detected.
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Figure 2.5 - Telomere lengths of different layers in the aorta of C57BL/6 mice
T/S ratios (+SD) were measured in different layers (intima, media, and adventitia) of the
aorta at 4 (N=8), 10 (N=8) and 14 (N=7) months of age in C57BL/6 mice. The intima of
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2.4.7

Aortic media referencing reveals age-dependent telomere
attrition in spleen and aortic intima of Diversity Outbred mice

Having identified the aortic media as a highly stable tissue with respect to telomere
length, I next sought to determine if this stability, and similarity to birth telomere length,
could be used to reference telomere length across a population of mice with genetic
diversity, akin to the human population. To address this, I measured telomere lengths in
Diversity Outbred (DO) mice, mice that are bred to maximize and maintain allelic
heterogeneity in the population. Furthermore, the DO population has been proposed to
have human-like genetic diversity and has been used for high resolution genetic mapping
(Svenson et al., 2012).
I first determined whether this genetic diversity would translate into changes in telomere
length, as well as length heterogeneity, compared to inbred mice. As shown in Figure
2.7A, mean telomere length of spleen DNA from DO mice (1-9 months old) was not
demonstrably different from those of inbred strains (1-9 months old). DO mice had
telomeres significantly longer than C57BL/6 (P<0.001) and shorter than Balb/c (P<0.05).
These results indicate that outbreeding and genetic heterogeneity, in and of themselves,
do not result in shortening of telomere lengths compared to inbred strains. However, the
inter-mouse variability of telomere length within DO mice was significantly greater than
that for each inbred strain evaluated and baseline variation. Thus, genetic diversity in
mice translates to diversity in telomere length.
I next determined if there was synchrony between aorta and spleen telomere lengths in
DO mice. Spleen and aortic media were harvested from 49 separate DO mice and
revealed an intra-mouse telomere length synchrony between aorta and spleen (R2=0.44,
P<0.0001) (Figure 2.7B). This synchrony suggests that genetic variation is a major
determinant of telomere length in individuals. I then determined the relationship of
telomere length with age in spleen and aortic media in DO mice, between 1 and 12
months of age. There was no obvious significant change in telomere length with age for
either spleen (Figure 2.7C) or aortic media (Figure 2.7D).
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I then referenced spleen telomere length using two different approaches, one previously
modeled on dogs (Benetos et al., 2011) using subtraction (Figure 2.7E) and the other
using division (Figure 2.7F). Both methods revealed a significant age-dependent
decrease in spleen telomere length relative to aortic media telomere length (P=0.0055 and
P=0.0029, respectively).
Moreover, we also used aortic media telomere length as a reference to assess the
relationship between intima telomere length and age. This was done using a mix of
C57BL/6 and DO mice between 1 and 16 months of age. I found that the correlation
coefficient for the relationship improved modestly from an R2=0.52 (P=0.0003) to
R2=0.58 (P=0.0001) and 0.61 (P<0.0001), based on subtraction and division, respectively
(Figure 2.8). Therefore, aortic media telomere length may provide a powerful tool to
more powerfully identify age-related changes in telomere lengths in leukocytes and the
vasculature, and DO mice are a good model to study the effects of genetic diversity on
telomere length dynamics with age.
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Figure 2.7 - Spleen telomere length referenced to aortic media telomere length as a
function of age in DO mice
A) Standard deviation of T/S ratios in spleen of 1-9 month old inbred mice (C57BL/6
N=25; Balb/c N=14; 129 N=14; SPRET/Ei N=3) and DO mice (N=34) with mean T/S
indicated above each bar. Baseline is the variation in T/S ratio from 10 tissue samples of
an individual spleen, representing the baseline variation derived from experimental
processes (***P<0.0001). Note that only T/S ratios of DO mice display a significant
increase in standard deviation compared to baseline variability. B) Synchrony of spleen
T/S ratio vs. aortic media T/S ratio in DO mice (N=49). C) Spleen T/S ratio with age in
DO mice (N=49). D) Aortic media T/S ratio with age in DO mice (N=49). Referencing
of spleen to aortic media T/S ratios by E) subtraction and F) division plotted against age
(1-12 months). The equation of the best fit line, R 2, and P-value are reported on each
graph.

83

B

2.0

Y= -0.072X+1.49
R2=0.52
P=0.0003

1.5
1.0
0.5

1

T/Sintima -T/Saorta

Telomere Length (T/S ratio)

A

Age (months)
4

0

4

8

12

16

age (months)

12

16

-1

-2

0.0

8

0

Y= -0.089X-0.17
R2=0.58
P=0.0001

C
(T/Sintima )/(T/S aorta )

2.0

Y= -0.045X+0.90
R2=0.61
P<0.0001

1.5
1.0
0.5
0.0
0

4

8

12

16

Age (months)

Figure 2.8 - Intima telomere lengths normalized to aortic media telomere lengths
with age
A) T/S ratios of genomic DNA harvested from the intima of the aortic wall with age (0.715.3 months) in a mix of C57BL/6 (N=14) and DO (N=6) mice. Intima T/S ratio was
referenced to aortic media by B) subtraction and C) division. The equation of the best fit
line, R2, and P-value are reported on each graph.

84

2.4.8

Telomere length shortening is induced by impaired collagen
turnover

Finally, having developed techniques to establish telomere length in mouse tissues, I
sought to determine if a pro-senescence stimulus would lead to telomere shortening in
tissues. Cardiac and arterial aging is characterized in part by senescent cells. Another
feature of cardiac disease and aging is abnormal remodeling of the extracellular matrix,
predisposing individuals for cardiovascular disease. With age, type I collagen shows
reduced turnover and increased cross-linking, leading to its accumulation in vascular
tissue (Jacob, 2003). During remodeling of vascular tissue, collagen fibrils are cleaved
between Gly775-Ile776 (in the α-1 chain) and Gly775-Leu776 (in the α-2 chain) by matrix
metalloproteinases (Birkedal-Hansen et al., 1993). One model of abnormal collagen
remodeling is the collagenase-resistant collagen mutant (Col1a1r/r) mice used in our lab.
These mice have a targeted base substitution of proline at residue 776, leading to
defective type I collagen turnover (Liu et al., 1995). Furthermore, these mice display
many premature aging phenotypes such as skin ulcerations, hair loss, high blood pressure
and predisposition to vascular senescence, suggesting that impaired collagen turnover is
causative to organismal aging (O’Neil C., Vafaie F., Pickering J.G., unpublished data).
Therefore, I decided to use this mouse model in order to determine if telomere shortening
in mice could be detected in a pathological state.
I examined telomere lengths in several tissues of old Col1a1r/r mutant and age-matched
wild-type mice. I chose tissues both abundant in collagen type I (heart, skeletal muscle
and aorta) as well as those lacking in this ECM protein (spleen and brain). Figure 2.9
shows that telomere lengths in heart and skeletal muscle of Col1a1r/r mice were
significantly shorter than in age-matched wild-type mice (P=0.006 and P=0.008,
respectively). A trend was observed in the aorta, but not statistically significant. In
contrast, spleen and brain showed no difference between mutant and wild-type mice. My
data suggested that defective collagen turnover in collagen-enriched tissues may
accelerate telomere attrition rate.

85

1.0

3.0

1.0
0.5

pe
ty
W
ild

M

Aorta

Skeletal muscle

M

W
ild

0.5

nt

ut
a

ty
p

e

nt

0.5

1.0

ut
a

1.0

1.5

e

1.5

P=0.008
2.0

ty
p

2.0

2.5

W
ild

P=0.14

2.5

M

W
ild

ty

ut
an

pe

t

0.5

1.5

t

1.5

P=0.47
2.0

ut
an

P=0.73

2.0

2.5

M

2.5

Telomere Length (T/S ratio)

3.0

Spleen
3.0

Telomere Length (T/S ratio)

Telomere Length (T/S ratio)
Telomere Length (T/S ratio)

3.0

Telomere Length (T/S ratio)

Brain
3.0

Heart
P=0.006

2.5
2.0
1.5
1.0

t
ut
an
M

W

ild

ty
pe

0.5
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2.5

Discussion

I have found that age-related changes in telomere length in mice are detectable but are
strain-specific. I also determined that aortic media telomere lengths are highly stable
with age and approximate telomere length at birth. Using aortic media, I showed that
age-related changes in telomere length can be uncovered in a DO mouse model system
that entails human-like genetic diversity. Finally, I showed that impaired collagen
turnover can lead to significant telomere shortening in vivo.

2.5.1

Strain-specific differences in telomere length dynamics

Few studies have studied strain-specific differences in telomere length set-point in mice.
In this study, I have shown that C57BL/6 mice have shorter telomeres than other inbred
strains (129 and Balb/c) and, as previously reported (Callicott and Womack, 2006;
Prowse and Greider, 1995), SPRET/Ei mice telomeres are significantly shorter than
C57BL/6 (Figure 2.1A).
There are only a few previous reports on telomere length differences among inbred
mouse strains. In line with our study, one report established that telomeres in tissues of
Balb/c mice were longer than those in C57BL/6 mice (Kipling and Cooke, 1990).
However, another study reported that in liver, telomeres of 129sv mice were shorter than
those in C57BL/6 mice (Hemann and Greider, 2000). This contrasts with what I
observed. Discrepancies between the studies could be explained by different telomere
length detection methods. Whereas Hemann and Greider used TRF analysis, I used
qPCR. TRF analysis detects subtelomeric regions, and the length detected is dependent
on restriction enzyme cut sites, which may differ between strains. Furthermore, the 129
strain used in this study is a combination of two specific substrains (129sv and 129P1/re).
However, as both substrains showed similar telomere lengths in my study (data not
shown), this is unlikely to be the cause of the discrepancies.
Telomere length of mesenchymal embryonic fibroblasts (MEF) from pure C57BL/6 mice
has been found to be shorter than that from 129sv:B6 (Canela et al., 2007), supporting my
data that C57BL/6 telomeres may be shorter than 129sv mice.

Furthermore, telomerase

knockout mice on a pure C57BL/6 background have shorter telomeres than the equivalent
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mutants with a mixed 129sv:B6 background and show pathologies sooner (Herrera et al.,
1999). These results support our finding that 129 background may have longer telomeres
than C57BL/6 background.
Currently, no study has looked at strain-specific changes in telomere length with age. I
detected that spleen from different inbred strains exhibit differential telomere length
dynamics with age. C57BL/6 mice showed age-related telomere shortening (Figure
2.2B), 129 mice showed no telomere length change with age (Figure 2.2C), and Balb/c
telomeres lengthened with age (Figure 2.2D). Similar to C57BL/6 in our study, a
previous study using wild-derived Mus Spretus mice showed significant telomere
shortening at a rate of -0.046kb per month in spleen (Coviello-McLaughlin and Prowse,
1997). It would be expected that tissues with a high cellular turnover like spleen have
shortening of telomere lengths with age. Balb/c and 129 mice may have a lengthening
mechanism at play, such as telomerase activity, to elongate and maintain their telomere
lengths. In fact, there is evidence that Balb/c mice may have active telomerase in spleen,
whereas C57BL/6 mice do not (Prowse and Greider, 1995).
Taken together, my data indicate strain-specific differences in telomere length set-point
and regulation over time. Of the strains studied, C57BL/6 displayed age-related
shortening of telomeres in a leukocyte-rich tissue.

2.5.2

Tissue-specific differences in telomere length dynamics of
C57BL/6 mice

After identifying a strain that shows age-related telomere shortening in a leukocyte-rich
tissue, I evaluated telomere length dynamics in a variety of tissue types. I looked at
tissues considered post-mitotic, such as muscle-rich tissues and brain, as well as those
with a high cellular turnover (bone marrow and blood). I observed that age has
differential impacts on different tissues in C57BL/6 mice (Figure 2.3).

2.5.2.1

Blood leukocytes

In somatic tissue with a rapid cell turnover like blood leukocytes, one would expect
telomeres to shorten with age. Interestingly, I did not detect statistical age-related
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shortening in blood leukocyte telomeres of C57BL/6 mice between the ages of 1 to 16
months (Figure 2.3). In contrast, a previous study with C57BL/6 mice showed significant
shortening in blood lymphocytes between 6 and 18 months of age (Rota et al., 2007). In
humans, telomeres of both blood lymphocytes and granulocytes are well established to
shorten with age both cross-sectionally (Oeseburg et al., 2010) and longitudinally (Aviv
et al., 2009; Chen et al., 2011). The fact I see no telomere shortening in blood
leukocytes raises the question of the validity of using C57BL/6 as a model for human
shortening with age. However, in the same human longitudinal studies, there is also
evidence of no change or even telomere lengthening in blood leukocytes of specific
individuals. Using TRF analysis, 68 out of 561 participants in the Bogalusa Heart Study
showed a gain in telomere length over a five year follow-up period (Aviv et al., 2009).
Notably, longitudinal evidence in wild-caught Mus musculus mice also showed telomere
lengthening with age by qPCR in blood lymphocytes collected at 3 and 12 months of age
(Ilmonen et al., 2008). Discrepancies between studies may be in part due to various
sources of inbred mice (suggesting genetic drift) and different detection and analysis
methods. Furthermore, blood cells come from various sources (thymus, bone marrow,
lymph nodes, and spleen), which may confound the validity of comparing telomere
lengths at different times.
It is also important to note that, in my study, telomere length of blood cells in young mice
(1-4 months of age; N=15-20) was significantly lower than those of other organs,
including spleen and bone marrow (T/S=1.13±0.24 vs. 1.52±0.17 and 1.57±0.51,
respectively, P<0.01). This suggests that murine blood cell telomeres may undergo
shortening early in life. In fact, I have preliminary evidence in leukocytes of C57BL/6
neonates suggesting this is the case (data not shown). This speculation is interestingly
consistent with well-established biphasic shortening of leukocyte telomeres with age in
humans and large mammals (Baerlocher et al., 2007; Rufer et al., 1999), but warrants
further experimental efforts. Telomere lengths of C57BL/6 leukocytes could be
followed longitudinally to confirm C57BL/6 mice as a model for human telomere
shortening with age. However, caution must be taken that extraction of blood does not
contribute to increased telomere shortening due to increased cell turnover to replace
blood cells.
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2.5.2.2

Bone marrow

It is well known that stem cell compartments are responsible for replenishing aged
somatic cells in tissue and that stem cells require telomerase activity to maintain their
telomere lengths (Flores et al., 2006). In this study, bone marrow exhibited a steady
decrease in telomere length from 1-16 months of age in wild-type C57BL/6 mice (Figure
2.3). This result suggests that telomerase activity in murine bone marrow is not high
enough to completely prevent telomere erosion in such a highly proliferative tissue. This
conclusion is supported by another study showing telomere shortening in stem cell
compartments of C57BL/6 mice (Ferron et al., 2009; Flores et al., 2008). Furthermore,
hematopoietic stem cells in humans had also been suggested to shorten with age (Aviv
and Levy, 2011) as a result of high cellular turnover.

2.5.2.3

Brain

Neurons are considered truly post-mitotic, undergoing little cell turnover after birth if any
(Bergmann et al., 2009; Spalding et al., 2005). Therefore, telomere lengths derived from
brain are expected to be stable with age. Surprisingly, in my study, brain exhibited a
steady decrease in telomere length with age (Figure 2.3). This is probably explained by
the fact that I assessed whole brain. Thus, the age-related telomere shortening may be
reflective of microglial cell turnover, as seen in rats (Flanary and Streit, 2004).
Moreover, our finding on brain is also consistent with previous reports in wild-type Mus
spretus and C57BL/6 mice (Coviello-McLaughlin and Prowse, 1997; Ferron et al., 2009;
Flores et al., 2008).

2.5.2.4

Heart

Cardiomyocytes are reported to have little turnover throughout adult life (Bergmann et
al., 2009) and may represent a good candidate surrogate for birth telomere length.
Consistent with this, I found no change in telomere length with age between 1 and 16
months of C57BL/6 mice (Figure 2.3). In contrast, another study showed significant
telomere shortening in cardiomyocytes between 6 and 18 months of age in wild-type
C57BL/6 mice (Rota et al., 2007). In CAST/Ei mice, telomeres significantly shortened
in the heart of sedentary mice in the first year, whereas exercise was protective against
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such shortening (Ludlow et al., 2012). Wistar rats showed extensive telomere shortening
only in the heart among other tissues measured (Hastings et al., 2004). These studies
suggest that telomeres in the heart may not be stable with age. Although I saw stable
telomere lengths with age in the heart, it was nonetheless highly variable. Furthermore,
it’s possible that most telomere shortening events occur between 1 and 2 years of age in
C57BL/6 mice, as suggested in another study (Flores et al., 2008). Notably, we also
observed a significant shortening event of heart telomeres between 1 day and 1 month of
age (Figure 2.4), suggesting it may not be an ideal choice for estimating birth telomere
length.

2.5.2.5

Skeletal muscle

Unlike cardiac muscle, skeletal muscle showed a significant decrease in telomere length
with age (Figure 2.3). Another study using C57BL/6 mice showed telomere shortening
in the diaphragm but not the tibialis anterior muscle of wild-type mice with age (Lund et
al., 2007). In CAST/Ei mice, unlike cardiac tissue, exercise induced telomere shortening
of the gastrocnemius, whereas sedentary mice showed no significant shortening in the
first year (Ludlow et al., 2012). Furthermore, in humans, endurance runners have
reduced telomere length in the vastus lateralis muscle, possibly because of increased load
on the skeletal muscle (Rae et al., 2010), whereas power-lifters have been reported to
have longer telomeres than non-athletes (Kadi et al., 2008). Therefore, telomere
shortening may be dependent on muscle type and mechanical stress applied to induce
regeneration during post-natal life. Nonetheless, two studies have used skeletal muscle as
an indicator of telomere length at birth (Benetos et al., 2011; Gardner et al., 2007) while
one review indicates to do so with caution (Kadi and Ponsot, 2010). At least in mice,
certain muscle types may be more reflective of neonatal telomere length than others. In
addition, the heterogeneous cell population in skeletal muscle tissues, including
myocytes, fibroblasts, vascular cells and blood cells (Biressi and Rando, 2010), could
contribute to the large telomere length variability observed in our study.
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2.5.2.6

Aortic media

The aorta was of particular interest because of the relative ease with which a
homogeneous population of smooth muscle cells (SMC) can be isolated, by harvesting
only the medial layer. A homogeneous cell population could help reduce variations in
telomere length through eliminating potential differences in telomere lengths between
cell types. Since SMCs do not replicate very often, except during injury or vascular
disease (McCarthy and Bennett, 2000), we were interested to see if the aortic media
showed a stable telomere length with age in wild-type mice. In C57BL/6 mice, we saw a
stable telomere length with time in the aortic media (Figure 2.3), and no significant
change with age in DO mice (Figure 2.7D). There is one study with C57BL/6 mice
showing telomere length in the aorta decreasing between 6 and 18 months of age (Werner
et al., 2009), but they use whole aorta sections. I have shown that the adventitia and
endothelium can differentially contribute to the results (Figure 2.5).

2.5.3

Aortic media has stable telomeres during early life
development

In order for a tissue to be a good indicator of birth telomere length, it would have to
maintain long and stable telomere lengths throughout the lifespan of an individual.
Skeletal muscle has previously been proposed as a good indicator of birth telomere length
(Benetos et al., 2011), however, here it showed signs of post-natal telomere shortening in
our study (Figure 2.3). Therefore, I looked at telomere lengths in the two myocyte
abundant tissue types showing no signs of post-natal shortening (cardiac and smooth
muscle) at birth compared to early life. I found that aortic media maintained stable
telomeres from birth to adulthood in these mice, whereas heart dropped significantly after
birth (Figure 2.4). No other study has looked at telomere length changes in early life of
mice. However, a study using Wistar rats demonstrated a 38% drop in telomere length
between newborns and adults in cardiac tissue (Hastings et al., 2004). Moreover, in my
study, aortic media had the longest telomeres at birth and post-natally compared to heart.
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Thus, aortic media displays stable telomere lengths during early life development and
adult aging. These results suggest that aortic media represents a surrogate for birth
telomere length.

2.5.4

Telo-mapping reveals telomere length heterogeneity in the
aorta

Different telomere length dynamics with age were observed in three circumferential
layers of mouse aorta (Figure 2.5). I identified that aortic intima, media, and adventitia
began with the same length of telomeres at early adulthood (4-months old). However, by
10 months the intimal layer had the shortest telomeres. This may be reflective of
hemodynamic and oxidative stress endothelial cells endure (Davies, 2009; Forstermann,
2010), exacerbating cellular turnover and telomere shortening. Also, telomere length in
the adventitia was shorter than that in the media, likely reflective of the heterogeneity in
the fibroblast population embedded in it, which have variable proliferation rates
compared to medial SMC cells (Stenmark et al., 2006). According to a previous study in
human abdominal aortas, the medial and intimal layers show no significant difference in
telomere length (Okuda et al., 2000). The difference between human and mice telomere
lengths in aorta layers may be reflective of differences in their cardiovascular physiology.
For example, murine hearts beat up to 10 times faster than human hearts, imposing a
greater degree of hemodynamic shear stress on mouse vessel walls (Ceconi et al., 2011).
Also, mouse aortic composition is different from humans – humans have a subendothelial layer of SMCs that is not present in mice (Schwartz and Benditt, 1972;
Schwartz et al., 1995).
Of note, I observed that aortic medial telomere length was significantly less in the infrarenal abdominal aorta compared to other segments above this (Figure 2.6). Different
regions of the aortic SMCs are of different developmental origins (Majesky, 2007), which
may contribute to the segmental variation in telomere lengths observed here. This
finding also raises the intriguing possibilities that shorter telomere length in the infrarenal abdominal aorta compared to other aortic regions contributes to its higher
susceptibility to vascular diseases, such as atherosclerosis and aortic aneurysms (Guo et
al., 2006). In fact, patients with abdominal aortic aneurysms have shorter telomeres in
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both aortic biopsies and blood leukocytes than age-matched controls (Atturu et al., 2010;
Wilson et al., 2008). Furthermore, a recent study shows that endothelial and smooth
muscle cells in patients with abdominal aortic aneurysm have shorter telomeres and
increased oxidative stress than controls matched for age and clinical history (Cafueri et
al., 2012). Therefore, it is possible that the vascular wall ages more readily in the
abdominal portion of the aorta and telomere length may represent a valuable indicator of
its diseased or aged state.

2.5.5

Diversity Outbred mice as a murine model for telomere
biology

Diversity Outbred mice are bred specifically to maintain maximum genetic heterogeneity
in its population. I determined that inter-mouse variability in telomere length is
correspondingly heterogeneous in the DO population, significantly greater than inbred
strains (Figure 2.7A). Evidently, genetic determinants play a fundamental role in
telomere length set-points of individual mice. A helicase called Rtel has been shown to
be critical in determining the set-point of telomeres in newborn mice (Ding et al., 2004).
Therefore, mice with diverse genetic backgrounds, like DO mice, may have diverse
telomere length set-points at birth. Another study showed that inbred lines also have an
innate heterogeneity in telomere length established in the parental germ-line (Zijlmans et
al., 1997). Nonetheless, my study showed that there was greater variability in telomere
length set-point in mice with greater genetic diversity.
I further showed that DO mice maintain long telomeres characteristic of inbred strains
from which they were derived (Chesler et al., 2008). This suggests that outbreeding does
not induce significant telomere shortening. Hemann and Greider discuss that wildderived strains have short telomeres because they were recently inbred, whereas the
appearance and maintenance of long telomeres in established strains is likely due to
extensive breeding of a small isolated colony (Hemann and Greider, 2000). Another
study argues that inbreeding may in fact induce telomere lengthening in mice (Manning
et al., 2002). Here I showed that extensive outbreeding of a large population of
genetically heterogeneous mice derived from established inbred strains does not restore
telomere lengths to human-like lengths, as proposed in wild-derived mice (Hemann and
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Greider, 2000), but rather maintains long telomeres. Furthermore, Hathcock et al. reports
that by crossing Mus spretus with Balb/c results in the lengthening of the short telomeres
from Mus spretus (Hathcock et al., 2005), suggesting that long telomeres may be
dominant to short ones. The inbred lines used to make the Collaborative Cross (CC)
strains and DO mice contain both long and short telomere lengths. Evidently, the short
telomeres from CAST/Ei mice (Hemann and Greider, 2000) were not selected for during
the outbreeding of these mice, further suggesting that long telomeres may be dominant to
short ones.

2.5.6

Correcting for telomere length heterogeneity in Diversity
Outbred mice

With aortic media (specifically supra-renal) representing a potential candidate for birth
telomere length, I wanted to dissect the contributions of age and genetic variation to
telomere length dynamics using the DO mouse model. I showed that an intra-mouse
telomere length synchrony exists between spleen and aorta in individual DO mice (Figure
2.7B), independent of inter-mouse variation in the DO population. Tissue telomere length
synchrony has been previously shown in macaques (Gardner et al., 2007), humans
(Gardner et al., 2007; Kimura et al., 2010; Wilson et al., 2008), dogs (Benetos et al.,
2011), and wild-derived mice (Prowse and Greider, 1995). Furthermore, such synchrony
has allowed the genetic variation of telomere length in a population to be accounted for
by subtracting telomere length of leukocyte from that of skeletal muscle, thereby
strengthening the association of telomere length with age (Benetos et al., 2011; Gardner
et al., 2007). My data indicate that aortic media may be a good choice, potentially better
than skeletal muscle.
With uncorrected data, DO mice showed no detectable telomere shortening in either
spleen (Figure 2.7C) or aorta (Figure 2.7D) with age. The DO spleen data is inconsistent
with C57BL/6 spleen data, which shows statistical telomere shortening with age (Figure
2.2B). This inconsistency may be due to the genetic diversity and large inter-mouse
variability in telomere lengths of DO mice. For instance, in one generation of DO mice
telomeres could be long, whereas in the next they could be shorter. Therefore, it’s
difficult to make any conclusive interpretations of telomere lengths with age in cross-
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sectional studies of a genetically diverse population. To offset genetic variability, I
applied two methods of referencing: subtraction (Figure 2.7E) and division (Figure 2.7F)
between spleen and aorta. I found improvements in the relationship of telomere length
with age, both becoming statistically significant. Both referencing methods have
different biological implications. Subtraction yields total spleen telomere length
shortening since birth, with the assumption that aortic media estimates birth telomere
length. Division normalizes telomere length to its presumed starting length, yielding
relative telomere length shortening.
Furthermore, these two referencing methods of subtraction and division also showed an
improvement in the age-related telomere shortening of the intima in a mixed population
of C57BL/6 and DO mice (Figure 2.8). Therefore, aortic media may act as a powerful
internal reference of birth telomere length to uncover age-related shortening of both
leukocytes and the endothelium.

2.5.7

Impaired collagen turnover accelerates telomere attrition

Finally, cardiovascular disease is an age-related phenotype that is in part characterized by
reduced arterial compliance and cardiac function, as well as accumulation of cross-linked
collagen fibrils (Jacob, 2003; Kovacic et al., 2011; Lakatta and Levy, 2003a, b). In this
study I revealed in a mutant collagen mouse model that has the same build-up of
extracellular matrix proteins, such as collagen type-I, in our heart and blood vessels that
leads to cardiovascular disease also shows a telomere length reduction compared to
healthy mice (Figure 2.9). Only those tissues that have an abundance of collagen
(skeletal muscle and heart) showed a significant reduction in telomere length. Therefore,
telomere length may be associated with age-related changes in extracellular matrix
proteins, such as collagen type I, that lead to cardiovascular disease.
In summary, these studies indicate that considerable data on telomere length can be
obtained from standard laboratory mice. Moreover, I propose that the aortic media has
unique attributes as a surrogate for birth telomere length.
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Chapter 3 - General Discussion
The major findings of this thesis are:
1) Mouse telomere lengths are strain-specific in both their set-point and rate of
attrition
2) Aortic media telomere length is stable in early life development and adult aging in
C57BL/6 mice
3) Telomere lengths are heterogeneous across the aortic wall in C57BL/6 mice
(intima<adventitia<media)
4) Genetic diversity translates to telomere length diversity in mice
5) Aortic media can act as a surrogate for birth telomere length to uncover agerelated relationships by referencing to leukocyte-rich tissues in a genetically
diverse mouse population
6) Impaired collagen turnover increases telomere length attrition in mice

3.1

Limitations and immediate next steps

First, an understanding of telomerase activity could inform findings of telomere length in
mice. For example, telomerase could be a contributing factor to aortic media telomere
lengths. Measuring telomerase activity in aortic media at different ages would determine
if telomerase activity contributes to its stability of telomere length with age or if minimal
cell turnover is the main cause. Furthermore, aortic media telomere lengths with age
could also be measured in a telomerase knockout model. As well, telomerase activity
could explain strain and tissue differences observed in my study.
Another key finding that merits further study was my observation that intima telomere
lengths shorten faster than those of the adventitia and aortic media. It would be
interesting to see if tissue-specific overexpression of telomerase could compensate for
this telomeric loss in the intima. Furthermore, would this compensation decrease the
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atherosclerotic burden of ApoE knockout mice, seeing as endothelial dysfunction is a
precursor to atherosclerosis? Moreover, it would also be interesting to see how the
telomere length gradient across the aortic wall is affected in a stressed system, such as
mice injected with angiotensin over time.
Moreover, the three layers of the aorta were isolated mechanically as best as possible, but
there was likely some cross-over between layers. However, it’s unlikely that the amount
of cross-over was enough to skew the telomere length measurement in any way.
However, Q-Fish could be performed on specific cells in the aorta to confirm that smooth
muscle cells have longer telomeres than endothelial cells in aged mice.
Lastly, I determined that impaired turnover of collagen in tissue has a negative impact on
telomere length with age. The composition of the extracellular matrix (ECM) plays an
important role to the health and function of tissue at a cellular level (Jacob, 2003). In
fact, the ECM contributes to the regulation of smooth muscle and endothelial cell
function (Hultgardh-Nilsson and Durbeej, 2007; Sottile, 2004). Increased mechanical
stress through an accumulation of collagen content may create an environment that
induces high cellular turnover, resulting in increased telomere attrition. Further studies
are necessary to assess the role of various ECM proteins on cell turnover and the rate of
telomere attrition. Telomere length may be a valuable marker for vascular aging and
pathogenesis. Notably, the aorta telomere lengths were unaffected by impaired collagen
turnover. In this experiment, I used whole aorta, and the collagen content varies between
layers, which may have skewed the results. Furthermore, a greater N number may be
necessary to detect statistical differences between the mutant (col1a1r/r) and wild-type
mice.

3.2

Future implications

I discovered that aortic media is a stable indicator of birth telomere length. Birth
telomere length has been shown to be a predictor of lifespan in birds (Heidinger et al.,
2012). It may be possible to use aortic media telomere length at a given age to predict
lifespan to some degree of accuracy. A large population study in humans would be
necessary to correlate aortic media telomere length to lifespan of the aging population
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using mortality as the endpoint. Such a study would validate the accuracy of using aortic
media in humans as an indicator of birth telomere length, assuming like in birds, birth
telomere length can predict lifespan in humans.
Human studies are necessary to validate use of aortic media as an internal reference for
birth telomere length to track telomere length changes in leukocyte-rich adult tissues. In
humans, access to aortic biopsies poses a potential problem, which may be limited to
patients undergoing surgery. However possible alternatives to aortic media may be the
umbilical cord or veins that are more accessible. Another possibility is use of a fragment
of the internal thoracic artery of patients undergoing bypass surgery. Future studies will
need to confirm the validity of such alternatives. Another issue in human studies is
vascular health status. For individuals in a diseased state, their aortic SMC’s may have
undergone proliferation and been exposed to increased oxidative stress and inflammation,
which would effectively shorten their telomere lengths (Cafueri et al., 2012; Okuda et al.,
2000). Studies will need to be performed that establish parameters for the use of aortic
media as an estimate of birth telomere length in humans.
Ultimately, if birth telomere length can be established in human adult tissue there are
implications for tracking telomere loss, telomere rate of shortening, and potential for
lifespan prediction. All of these readouts will allow investigators to further elucidate how
telomeres are associated with age and age-related illnesses for an individual and the
human population.

3.2.1

Model for estimating birth telomere length

I determined telomere length dynamics with age in a variety of post-mitotic tissues
(brain, skeletal muscle, heart, aortic media) and tissues with high cellular turnover
(spleen, blood, bone marrow). Not only was aortic media telomere lengths the most
stable with age, but it tended to maintain the longest telomeres of all tissues measured.
These results may in part be reflective of the cell composition of each tissue type. In fact,
I noticed higher inter- and intra-mouse variability of telomere lengths in some tissues
compared to others; heart and skeletal muscle was often high (data not shown). Telomere
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length variability between tissue types may be dependent on how homogeneous the cell
population is in type, age and distribution in a given tissue sample. For instance, a study
by Rota et al. showed that the mouse heart is composed of myocytes heterogeneous in
age and function, such that telomere lengths varied from 14 to 58 kbp with the largest and
oldest myocytes having the shortest telomeres (Rota et al., 2007). This heterogeneity of
myocytes in age likely contributes to the relatively high variability seen in telomere
lengths of heart samples in our study. Another study by González-Suárez et al. measured
telomere lengths of metaphase spreads using qFISH and showed significant amount of
variation within a given tissue (Gonzalez-Suarez et al., 2005), suggesting that tissues are
composed of individual cells with varying telomere lengths. Moreover, telomere lengths
of keratinocytes in the basel layer of skin had less variation than telomere lengths in
kidney sections (Gonzalez-Suarez et al., 2005), further supporting the notion that
different tissue types have greater variation in telomere lengths than others.
Previous studies have shown that skeletal muscle may be a good choice as a surrogate
marker for birth telomere length in adults (Benetos et al., 2011; Gardner et al., 2007).
However, skeletal muscle is composed of a variety of different cell types, including a
proliferating population of satellite stem cells (Biressi and Rando, 2010). Estimating
birth telomere length requires that the tissue sampled be composed predominantly of
post-mitotic cells as shown in figure 3.1. This would effectively reduce any noise or
skewing effect caused by specific cell populations in tissues that have undergone
extensive proliferation post-natally.

3.2.2

Diversity Outbred mouse model to study genetic diversity
and telomere length dynamics

The Diversity Outbred (DO) mice showed extensive variation in telomere lengths
compared to inbred mice. Thus, DO mice may prove to be a valuable tool to study the
effects of genetic heterogeneity on telomere length dynamics in genome wide association
studies (GWAS) to identify critical modulators of telomere length. In fact, a recent study
demonstrated that DO mice can be used for high resolution genetic mapping with
minimal number of mice (Svenson et al., 2012).
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Figure 3.1 - Estimating birth telomere length
Post-mitotic tissues are composed of both post-mitotic cells and mitotic cells in different
proportions. Mitotic cells undergo proliferation and telomere shortening events, whereas
post-mitotic cells do not divide and show no significant telomere shortening. A tissue
predominantly composed of post-mitotic cells will have the most accurate representation
of birth telomere length. However, the greater the proportion of mitotic cells in the tissue
sample, the further away it will be from true birth telomere length.
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Furthermore, these mice showed diverse physiologies from plasma lipid and glucose
levels, hematological parameters, to body composition (Svenson et al., 2012), and as I
have also shown in telomere lengths. It would be interesting to see if DO mice born with
short telomeres have a predisposition to age-related illnesses compared to those born with
long telomeres.
The implications of having a good estimate of birth telomere length, such as aortic media,
may allow investigators to take a snap-shot of an individual’s leukocyte telomere length
at a given age relative to their starting point. Referencing in this way might enable
investigators to determine telomere loss and rate of telomere shortening of an individual.
Although actual telomere length is an important readout, both telomere loss and rate of
shortening may also be important readouts to further establish an etiological role of
telomeres with aging and disease. Those two readouts could also be applied to GWAS
studies in large populations of individuals to determine genetic variants that contribute to
telomere attrition with age. One study in particular looked at 743 SNPs in 43 telomere
biology genes in 3646 participants of the prostate, lung, Colorectal, and ovarian screening
trial and Nurse’s health study and found no strong associations with telomere length
(Mirabello et al., 2010). They propose it may have been due to a lack of diversity and/or
evolutionary conservation. The DO mice may provide the allelic variation and statistical
power necessary in order to detect SNP variants associated with telomere length.
Therefore, DO mice have extensive genetic and telomere length heterogeneity with
potential to further elucidate the complexity of aging and its association with telomere
length.

3.3

References

Benetos, A., Kimura, M., Labat, C., Buchoff, G.M., Huber, S., Labat, L., Lu, X., and
Aviv, A. (2011). A model of canine leukocyte telomere dynamics. Aging Cell.
Biressi, S., and Rando, T.A. (2010). Heterogeneity in the muscle satellite cell population.
Semin Cell Dev Biol 21, 845-854.
Cafueri, G., Parodi, F., Pistorio, A., Bertolotto, M., Ventura, F., Gambini, C., Bianco, P.,
Dallegri, F., Pistoia, V., Pezzolo, A., et al. (2012). Endothelial and smooth muscle cells
from abdominal aortic aneurysm have increased oxidative stress and telomere attrition.
PLoS One 7, e35312.

109

Gardner, J.P., Kimura, M., Chai, W., Durrani, J.F., Tchakmakjian, L., Cao, X., Lu, X., Li,
G., Peppas, A.P., Skurnick, J., et al. (2007). Telomere dynamics in macaques and
humans. J Gerontol A Biol Sci Med Sci 62, 367-374.
Gonzalez-Suarez, E., Geserick, C., Flores, J.M., and Blasco, M.A. (2005). Antagonistic
effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24,
2256-2270.
Heidinger, B.J., Blount, J.D., Boner, W., Griffiths, K., Metcalfe, N.B., and Monaghan, P.
(2012). Telomere length in early life predicts lifespan. Proc Natl Acad Sci U S A 109,
1743-1748.
Hultgardh-Nilsson, A., and Durbeej, M. (2007). Role of the extracellular matrix and its
receptors in smooth muscle cell function: implications in vascular development and
disease. Curr Opin Lipidol 18, 540-545.
Jacob, M.P. (2003). Extracellular matrix remodeling and matrix metalloproteinases in the
vascular wall during aging and in pathological conditions. Biomed Pharmacother 57,
195-202.
Mirabello, L., Yu, K., Kraft, P., De Vivo, I., Hunter, D.J., Prescott, J., Wong, J.Y.,
Chatterjee, N., Hayes, R.B., and Savage, S.A. (2010). The association of telomere length
and genetic variation in telomere biology genes. Hum Mutat 31, 1050-1058.
Okuda, K., Khan, M.Y., Skurnick, J., Kimura, M., Aviv, H., and Aviv, A. (2000).
Telomere attrition of the human abdominal aorta: relationships with age and
atherosclerosis. Atherosclerosis 152, 391-398.
Rota, M., Hosoda, T., De Angelis, A., Arcarese, M.L., Esposito, G., Rizzi, R., Tillmanns,
J., Tugal, D., Musso, E., Rimoldi, O., et al. (2007). The young mouse heart is composed
of myocytes heterogeneous in age and function. Circ Res 101, 387-399.
Sottile, J. (2004). Regulation of angiogenesis by extracellular matrix. Biochim Biophys
Acta 1654, 13-22.
Svenson, K.L., Gatti, D.M., Valdar, W., Welsh, C.E., Cheng, R., Chesler, E.J., Palmer,
A.A., McMillan, L., and Churchill, G.A. (2012). High-resolution genetic mapping using
the Mouse Diversity outbred population. Genetics 190, 437-447.

110

Appendices
Appendix A: Statement of permission for the use of animals for experimental
research
All animal experimentation was conducted in compliance with the animal use protocol
2010-244 held by Dr. J. Geoffrey Pickering, principal investigator at the Schulich School
of Medicine and Dentistry and the Department of Biochemistry at the University of
Western Ontario in London, Ontario, Canada.
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Appendix B: Sample calculation of qPCR telomere length measurement (T/S ratio)
Relative telomere length by quantitative PCR (qPCR) was determined by measuring the
factor by which each experimental sample differed from a reference DNA sample in its
ratio of telomere repeat copy number to single gene copy number (Cawthon, 2002). In
theory, this ratio should be proportional to the average telomere length. The quantity of
telomeric repeats and single copy gene is best described from the original paper by
Cawthon. “The quantity of telomere repeats in each experimental sample was measured
as the level of dilution of an arbitrarily chosen reference DNA sample that would make
the experimental and reference samples equivalent with regard to the number of cycles of
PCR needed to generate a given amount of telomere PCR product during the exponential
phase of PCR amplification. Similarly, the relative quantity of the single copy gene in
each experimental sample was expressed as the level of dilution of the reference DNA
sample needed to match it to the experimental sample with regard to the number of cycles
of PCR needed to generate a given amount of single copy gene PCR product during the
exponential phase of the PCR. For each experimental sample the ratio of these dilution
factors is the relative telomere to single copy gene (T/S) ratio (Cawthon, 2002).”
First, a standard curve for both telomeric repeats and single copy gene (36B4) was
generated using an arbitrarily chosen reference DNA sample by serial dilution (Figure
4.1). The reference DNA sample can be from a single individual or pooled from many.
In this thesis, I chose spleen DNA of an individual mouse as the reference DNA sample
because spleen is concentrated in cells and therefore DNA is easily extracted in large
amounts.
Second, a Ct value is determined for each well by quantitative PCR. Ct value is defined
as the fractional cycle number at which accumulating fluorescence in a given well crosses
a set threshold. This threshold can be manually adjusted or automatically set several
standard deviations above baseline fluorescence. In this thesis, I manually adjusted the
threshold to optimize the reaction efficiency and achieve a slope between -3.1 and -3.6
for both the telomere and 36B4 standard curve.
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Figure 4.1 – Standard curve generated to determine a T/S ratio.
Serial dilution of an arbitrarily chosen reference DNA sample was used to generate a
standard curve for both telomeric repeats and a single copy gene (36B4). Experimental
samples (unknowns) are quantified based on matched Ct values relative to standard curve
for telomeric repeats or 36B4.
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Furthermore, baseline fluorescence is automatically set between cycle 3 and 15.
However, amplification of telomeric repeats results in a fluorescent signal that passes the
cycle threshold well before cycle 15. Therefore, I manually adjusted the baseline
fluorescence for telomere qPCRs to be between cycle 2 and 6.
Third, a plot of Ct versus log (amount of input target DNA) is linear, which allows simple
relative quantitation of unknowns by comparison to both the telomere and 36B4 standard
curves.

For this thesis, telomere (T) PCRs and single copy gene (S) PCRs were always

performed in separate 384-well plates. A standard curve was included in each plate.
Applied Biosystems SDS software v2.4 was used to generate the standard curve for each
plate and to determine the dilution factors of reference DNA corresponding to the T and
S amounts in each sample. A T/S ratio for each experimental sample was then
determined. An example derivation of T/S ratios of three unknown samples (A, B, and
C) from figure 4.1 can be seen in table 4.1.
Table 4.1 – Sample calculation of T/S ratio
Unknown
sample
A
B
C

Log T
quantity (ng)
0.1
0.4
0.7

T quantity
(ng)
1.26
2.51
5.01

Log S
quantity (ng)
0.3
0.5
0.6

S quantity
(ng)
2.00
3.16
3.98

T/S ratio
0.63
0.79
1.26

If the T/S ratio is equal to 1, the experimental sample has an average telomere length
equivalent to the reference DNA sample. If T/S ratio is above or below 1 then the
experimental sample has an average telomere length respectively greater or less than the
reference sample. T/S ratios of samples within a laboratory can be compared relative to
each other, but comparisons of T/S ratios between laboratories cannot be made unless
converted to kilobases using universal standards (currently do not exist). It is important
to note that qPCR generated T/S ratios may not be directly linear with absolute telomere
length as measured in kilobases by Southern blotting. One study impartially compared
the qPCR and TRF analysis of the same leukocyte DNA samples between laboratories
(Aviv et al., 2011). Results indicated that the two methods are correlated, but may
deviate from linearity. Addition of a quadratic term improved the fit between both
methods. This result suggests that when comparing T/S ratios, differences must be
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interpreted with caution. Differences in T/S ratios may not be directly proportional to
actual telomere length differences. However, differences in T/S ratios can still be
statistically identified and interpreted as such.
Lastly, a standard curve slope between -3.1 and -3.6 represents reaction efficiency
between 90-110%, which is deemed acceptable. Variations in reaction efficiencies
between experiments can cause variations in T/S ratios. These variations were accounted
for by using inter-experimental plate controls. These controls were seven arbitrary
samples of DNA that were included in each plate. An average T/S ratio for each control
was determined based on seven experiments. The average T/S ratio for each control was
used as a baseline for individual runs to determine a factor by which T/S ratios deviated
for a given run. The ratio between baseline and experimental T/S ratio of each control
was determined and the average of these seven values was used as the factor to normalize
T/S ratios of a given experiment.
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